Anatomical movements

Anatomical movements

by with No Comment Physiology

ANATOMICAL MOVEMENTS

Anatomy: Planes, Axes, and Movements
ANATOMY & KINESIOLOGY

Introduction to Anatomical Planes

Understanding anatomical planes is fundamental to describing the location of structures and, more importantly, the direction of movement within the human body. These are imaginary flat surfaces that pass through the body, dividing it into sections. All movements occur within or parallel to these planes.

A. Standard Anatomical Position Reminder:

Before discussing planes, it's crucial to recall the standard anatomical position:

  • Body erect
  • Feet slightly apart
  • Palms facing forward
  • Thumbs pointing away from the body

All descriptions of planes and movements assume the body is in this position.

B. The Three Cardinal Planes:

1. Sagittal Plane

  • Definition: A vertical plane that divides the body or an organ into right and left parts.
  • Orientation: Runs vertically from front to back.
  • Key Divisions:
    • Midsagittal (Median) Plane: Lies exactly in the midline, dividing the body into equal right and left halves. Often used as a reference point.
    • Parasagittal Planes: All other sagittal planes offset from the midline, dividing the body into unequal right and left parts.
  • Movements Associated: Primarily flexion and extension. These involve anterior-posterior motion.
  • Analogy: Imagine a wall cutting through your body from your nose to your spine.

2. Frontal (Coronal) Plane

  • Definition: A vertical plane that divides the body or an organ into anterior (front) and posterior (back) parts.
  • Orientation: Runs vertically from side to side, perpendicular to the sagittal plane.
  • Movements Associated: Primarily abduction and adduction. These involve medial-lateral motion.
  • Analogy: Imagine a wall cutting through your body from one shoulder to the other.

3. Transverse (Horizontal) Plane

  • Definition: A horizontal plane that divides the body or an organ into superior (upper) and inferior (lower) parts.
  • Orientation: Runs horizontally, perpendicular to both sagittal and frontal planes.
  • Key Divisions: Often referred to as cross-sectional planes, especially in imaging (e.g., CT scans, MRIs).
  • Movements Associated: Primarily rotational movements (medial/internal and lateral/external rotation).
  • Analogy: Imagine a table slicing through your body at the waist.

C. Clinical Relevance of Planes:

  • Medical Imaging: Radiologists extensively use these planes to orient images (e.g., MRI, CT, ultrasound) and describe the location of pathologies.
  • Surgical Planning: Surgeons plan incisions and approaches based on anatomical planes.
  • Rehabilitation: Therapists describe exercises and patient movements in relation to these planes to ensure correct form and target specific muscle groups.
  • Biomechanics: Researchers analyze human movement by breaking it down into components occurring in specific planes.

II. Anatomical Axes of Rotation

Movement at a joint occurs around an imaginary line called an axis of rotation. Each axis is perpendicular to the plane in which the movement occurs. Think of the axis as a pivot point around which the bone rotates.

A. The Three Major Axes:

  1. Mediolateral (Transverse) Axis:
    • Orientation: Runs horizontally from side to side (left to right or right to left).
    • Relationship to Planes: Perpendicular to the sagittal plane.
    • Movements Associated: Movements that occur in the sagittal plane, such as flexion and extension.
      • Example: Bending your elbow (flexion) or straightening it (extension) occurs around a mediolateral axis passing through the elbow joint.
  2. Anteroposterior (Sagittal) Axis:
    • Orientation: Runs horizontally from front to back (anterior to posterior or posterior to anterior).
    • Relationship to Planes: Perpendicular to the frontal (coronal) plane.
    • Movements Associated: Movements that occur in the frontal plane, such as abduction and adduction.
      • Example: Lifting your arm out to the side (abduction) or bringing it back to your body (adduction) occurs around an anteroposterior axis passing through the shoulder joint.
  3. Vertical (Longitudinal) Axis:
    • Orientation: Runs vertically from superior to inferior (up and down).
    • Relationship to Planes: Perpendicular to the transverse (horizontal) plane.
    • Movements Associated: Movements that occur in the transverse plane, primarily rotational movements (medial/internal rotation, lateral/external rotation).
      • Example: Turning your head left and right (rotation of the neck) occurs around a vertical axis passing through the cervical spine. Rotating your arm inward or outward at the shoulder also occurs around a vertical axis.

B. Summary Table:

Plane of Movement Axis of Rotation Primary Movements
Sagittal Mediolateral (Transverse) Flexion, Extension
Frontal (Coronal) Anteroposterior (Sagittal) Abduction, Adduction
Transverse (Horizontal) Vertical (Longitudinal) Rotation (Medial/Lateral)

C. Importance of Axes:

  • Biomechanics: Crucial for analyzing the mechanics of movement and understanding forces acting on joints.
  • Exercise Science: Helps in designing exercises that target specific planes of motion and strengthen muscles responsible for movements around particular axes.
  • Prosthetics and Orthotics: Design of artificial limbs and braces must consider the natural axes of human joint movement.
Activity for Students: To reinforce understanding, perform simple movements and identify the plane and axis for each:
  1. Nodding head "yes" (flexion/extension)
  2. Shaking head "no" (rotation)
  3. Jumping jacks (abduction/adduction of arms and legs)
  4. Bicep curl (flexion/extension of elbow)
  5. Trunk rotation

III. Classification of Anatomical Movements

Anatomical movements are typically described at synovial joints, which allow for a wide range of motion. Movements are often described in pairs, as they are opposing actions.

A. Movements in the Sagittal Plane (around a Mediolateral Axis):

1. Flexion:

  • Definition: Movement that decreases the angle between two body parts. For most joints, this involves bringing the anterior surfaces closer together, or in the case of the knee and elbow, bringing posterior surfaces closer.
  • Examples:
    • Shoulder: Bringing the arm forward and upward.
    • Elbow: Bending the arm, bringing the forearm closer to the upper arm.
    • Wrist: Bending the hand anteriorly towards the forearm.
    • Hip: Bringing the thigh forward and upward.
    • Knee: Bending the leg, bringing the heel towards the buttocks.
    • Trunk/Spine: Bending forward at the waist.
    • Neck: Bending the head forward, chin towards the chest.
  • Key Muscles (Examples): Biceps brachii (elbow), Pectoralis major (shoulder), Iliopsoas (hip), Hamstrings (knee).

2. Extension:

  • Definition: Movement that increases the angle between two body parts, effectively straightening the joint. It is generally the reverse of flexion.
  • Hyperextension: Extension beyond the normal anatomical limit. This can indicate injury or hypermobility.
  • Examples:
    • Shoulder: Moving the arm backward from the anatomical position.
    • Elbow: Straightening the arm.
    • Wrist: Straightening the hand with the forearm (or moving it posteriorly).
    • Hip: Moving the thigh backward.
    • Knee: Straightening the leg.
    • Trunk/Spine: Bending backward at the waist.
    • Neck: Extending the head backward.
  • Key Muscles (Examples): Triceps brachii (elbow), Latissimus dorsi (shoulder), Gluteus maximus (hip), Quadriceps femoris (knee).

B. Movements in the Frontal (Coronal) Plane (around an Anteroposterior Axis):

1. Abduction:

  • Definition: Movement of a limb or body part away from the midline of the body.
  • Exceptions: Fingers/toes: away from the midline of the hand/foot.
  • Examples:
    • Shoulder: Lifting the arm out to the side.
    • Hip: Moving the leg out to the side.
    • Fingers/Toes: Spreading them apart.
  • Key Muscles (Examples): Deltoid (shoulder), Gluteus medius/minimus (hip).

2. Adduction:

  • Definition: Movement of a limb or body part towards the midline of the body.
  • Exceptions: Fingers/toes: towards the midline of the hand/foot.
  • Examples:
    • Shoulder: Bringing the arm back towards the body from an abducted position.
    • Hip: Bringing the leg back towards the other leg from an abducted position.
    • Fingers/Toes: Bringing them together.
  • Key Muscles (Examples): Pectoralis major, Latissimus dorsi (shoulder), Adductor group (thigh).

C. Movements in the Transverse (Horizontal) Plane (around a Vertical Axis):

1. Medial (Internal) Rotation:

  • Definition: Rotational movement of a limb towards the midline of the body (turning the anterior surface inward).
  • Examples:
    • Shoulder: Turning the arm inward so the palm faces posteriorly (if elbow bent to 90 degrees).
    • Hip: Turning the leg inward so the toes point medially.
  • Key Muscles (Examples): Subscapularis, Pectoralis major (shoulder), Gluteus medius/minimus (hip).

2. Lateral (External) Rotation:

  • Definition: Rotational movement of a limb away from the midline of the body (turning the anterior surface outward).
  • Examples:
    • Shoulder: Turning the arm outward so the palm faces anteriorly (if elbow bent to 90 degrees).
    • Hip: Turning the leg outward so the toes point laterally.
  • Key Muscles (Examples): Infraspinatus, Teres minor (shoulder), Obturator internus/externus (hip).

D. Combination Movement:

1. Circumduction:

  • Definition: A combination of flexion, extension, abduction, and adduction movements, resulting in a conical movement of the distal end of a limb while the proximal end remains relatively stable. It can be seen at ball-and-socket joints.
  • Examples:
    • Shoulder: Moving the arm in a circle (e.g., pitching a softball).
    • Hip: Moving the leg in a circle.
    • Wrist: Making circles with your hand.
  • Key Muscles: Involves sequential activation of muscles responsible for flexion, extension, abduction, and adduction at the joint.

E. Special Movements:

These movements are typically specific to certain joints or body regions.

1. Elevation & 2. Depression

Elevation: Movement in a superior (upward) direction.
Scapula: Shrugging. Mandible: Closing mouth.
Muscles: Trapezius, Temporalis, Masseter.

Depression: Movement in an inferior (downward) direction.
Scapula: Lowering shoulders. Mandible: Opening mouth.
Muscles: Trapezius, Pectoralis minor, Platysma.

3. Protraction & 4. Retraction

Protraction (Protrusion): Anteriorly (forward) in the transverse plane.
Scapula: Rounding forward. Mandible: Jutting jaw forward.
Muscles: Serratus anterior, Pectoralis minor.

Retraction (Retrusion): Posteriorly (backward) in the transverse plane.
Scapula: Pulling back. Mandible: Pulling jaw backward.
Muscles: Rhomboids, Trapezius.

5. Dorsiflexion & 6. Plantarflexion

Dorsiflexion: Ankle joint; decreases angle between top of foot and anterior tibia (toes up).
Muscles: Tibialis anterior.

Plantarflexion: Ankle joint; increases angle between top of foot and anterior tibia (toes down/tiptoes).
Muscles: Gastrocnemius, Soleus.

7. Inversion & 8. Eversion

Inversion: Sole turns medially (inward).
Muscles: Tibialis anterior/posterior.

Eversion: Sole turns laterally (outward).
Muscles: Fibularis longus/brevis.

9. Pronation & 10. Supination (Forearm)

Pronation: Palm faces posteriorly (or inferiorly). Radius crosses ulna.
Muscles: Pronator teres/quadratus.

Supination: Palm faces anteriorly (anatomical position). Radius and ulna are parallel.
Muscles: Supinator, Biceps brachii.

11. Opposition & 12. Reposition

Opposition: Thumb across palm to touch tips of other fingers. Essential for grasping.
Muscles: Opponens pollicis.

Reposition: Thumb back to anatomical position.

13. Radial & 14. Ulnar Deviation

Radial Deviation (Abduction): Hand moves laterally towards thumb side.
Muscles: Flexor/Extensor carpi radialis.

Ulnar Deviation (Adduction): Hand moves medially towards little finger side.
Muscles: Flexor/Extensor carpi ulnaris.

Clinical Correlation / Application:
  • Range of Motion (ROM) Assessment: Clinicians assess ROM in various planes to diagnose injuries and track rehab.
  • Gait Analysis: Understanding joint movements is crucial for analyzing walking patterns.
  • Neurological Examination: Assessing specific movements helps localize neurological lesions.

IV. Joint Structure and Its Influence on Movement

The design of a joint is the primary determinant of the range and types of motion. Synovial joint classification is based on the shape of articulating surfaces.

A. Functional Classification (Degrees of Freedom):

  • Uniaxial: Movement in one plane around one axis (e.g., hinge, pivot).
  • Biaxial: Movement in two planes around two axes (e.g., condyloid, saddle).
  • Multiaxial: Movement in three or more planes around three or more axes (e.g., ball-and-socket).

B. Types of Synovial Joints and Their Movements:

Joint Type Structure & Movement Examples
1. Plane (Gliding) Flat surfaces. Short, nonaxial gliding/slipping. Range: Very limited (stability). Intercarpal, intertarsal, facet joints of vertebrae.
2. Hinge Cylindrical end in trough. Uniaxial (Sagittal). Primarily Flexion/Extension. Elbow (humeroulnar), knee (modified), interphalangeal.
3. Pivot Rounded end in a sleeve/ring. Uniaxial (Vertical axis). Only Rotation. Atlantoaxial (C1-C2), proximal radioulnar.
4. Condyloid (Ellipsoidal) Oval surface in oval depression. Biaxial (Flex/Ext and Abd/Add). Circumduction possible. Radiocarpal (wrist), Metacarpophalangeal (2-5).
5. Saddle Complementary concave/convex areas. Biaxial. Allows opposition/reposition. Carpometacarpal of the thumb.
6. Ball-and-Socket Spherical head in cup-like socket. Multiaxial. Freest range of motion in all planes. Shoulder (glenohumeral), hip (acetabulofemoral).

C. Factors Affecting Joint Mobility:

  • Articular Cartilage: Smoothness reduces friction.
  • Ligaments: Connect bones; provide stability and limit excessive movement.
  • Joint Capsule: Encloses the joint, providing containment.
  • Muscles and Tendons: Cross the joint; provide dynamic stability.
  • Bony Anatomy: Shape can restrict movement (e.g., olecranon process limits elbow extension).
  • Soft Tissue Apposition: Contact of soft tissues (e.g., muscle bulk) can limit movement.
  • Genetics and Age: Individual variation and decreased elasticity impact flexibility.

V. Clinical Scenarios: Abnormal Movements and Range of Motion

Understanding normal movements is critical for identifying pathologies. Deviations from normal range or pain are significant indicators.

A. Limitations in Range of Motion (ROM):

1. Causes:

  • Injury: Fractures, dislocations, sprains, strains.
  • Inflammation: Arthritis (rheumatoid, osteoarthritis), bursitis, tendinitis.
  • Scar Tissue/Fibrosis: Restricts movement post-trauma/surgery.
  • Muscle Spasm/Tightness: Limits joint mobility.
  • Neurological Conditions: Spasticity, rigidity, paralysis (e.g., stroke, spinal cord injury).
  • Congenital Anomalies: Issues in joint formation.
  • Pain: Often the primary limiting factor.

2. Clinical Assessment:

  • Goniometry: Using a goniometer to objectively measure joint angles.
  • Active ROM (AROM): Patient moves joint independently. Assesses strength/coordination.
  • Passive ROM (PROM): Clinician moves the joint. Assesses integrity/restrictions.
  • End-Feels: Sensation at the end of PROM (soft, firm, hard, empty).

B. Abnormal Movement Patterns:

  1. Compensation: Using alternative muscles/body parts due to weakness (e.g., elevating shoulder to assist arm abduction).
  2. Ataxia: Incoordination; staggering gait (cerebellar dysfunction).
  3. Dyskinesia: Involuntary, repetitive, bizarre movements.
  4. Tremor: Rhythmic, oscillatory movement.
  5. Spasticity/Rigidity:
    • Spasticity: Velocity-dependent resistance ('clasp-knife').
    • Rigidity: Non-velocity-dependent ('lead-pipe' or 'cogwheel').
  6. Flaccidity: Absence of muscle tone; limp limb.

C. Pathologies and Their Impact on Movement:

  • Osteoarthritis: Degeneration leads to pain/stiffness (e.g., limited knee flexion).
  • Rotator Cuff Tear: Impairs abduction and rotation.
  • Ankle Sprain: Limits inversion/eversion; causes pain with weight-bearing.
  • Stroke: Can lead to hemiparesis or hemiplegia.
  • Scoliosis: Abnormal lateral curvature affecting trunk rotation.

VI. Utilizing Appropriate Anatomical Terminology

Accurate communication is paramount. Using precise terms avoids ambiguity.

A. Key Principles:

  • Standard Anatomical Position: All descriptions default to this.
  • Planes and Axes: Always specify both for complex motions.
  • Paired Terms: Use opposing terms (Flex/Ext) for clarity.
  • Specificity: Say "shoulder abduction" instead of "arm movement."
  • Context: Mind the context (e.g., forearm pronation vs. foot pronation).

B. Practice and Application:

  • Case Studies: Analyze scenarios and describe limitations.
  • Peer Discussion: Intentionally use anatomical terms.
  • Documentation: Use precise language in patient charts/reports.
Anatomy: Anatomical Movements Quiz
Logo

Anatomical Movements

Test your knowledge with these 20 questions.

ELECTROCARDIOGRAM INTERPRETATION

ELECTROCARDIOGRAM INTERPRETATION

by with No Comment Physiology

ELECTROCARDIOGRAM INTERPRETATION

ELECTROCARDIOGRAM (ECG)

Electrocardiogram is a graphic record of algebraic summed potentials generated by the heart, recorded from the surface of the body using an electrocardiograph machine.

The magnitude, polarity, and configuration of the recorded electrocardiogram depends on the location of the recording leads placed on the body surface. The process of recording an electrocardiogram is called electrocardiography.

Aims and Objectives

  • Carry out electrocardiography correctly and successfully.
  • Interpret the electrocardiogram recorded.
  • Relate the interpretation with the heart status.
  • Assess the functional integrity of the heart.
  • Suggest the appropriate remedy if any that can improve the status detected.

Requirements

  • Functional Electrocardiograph machine & accessories
  • Volunteer subject
  • Volunteer ECG operator
  • Couch with linen
  • Screen (for privacy)
  • Cotton wool/tissue and spirit/alcohol

Procedure

  1. The lab technician/tutor will introduce the electrocardiograph machine in use with its operational procedures.
  2. The procedure of electrocardiography will be thoroughly explained to the volunteer subject by the volunteer operator.
  3. The subject will be screened off, asked to undress to expose the chest, both upper limbs and both legs.
  4. The subject then lies on his or her back on the couch, and relaxes while breathing quietly throughout the procedure.
  5. The rest of the body surface that is not to be used is covered with linen.
  6. The volunteer ECG operator prepares the surfaces for the leads electrodes attachment by clearing it with cotton wool soaked in alcohol or spirit.
  7. Thinly coat the surfaces prepared with salt enriched electrode jelly and proceed to strap electrodes appropriately.
  8. Record manually lead by lead till you get all the 12 leads designated, then proceed to record automatically all the 12 leads record as well.
  9. Label the electrocardiogram recorded with the volunteer's particulars namely: Name, Sex, Age, time of recording, any medicines taken, and finally any known medical condition the volunteer subject has.
  10. Switch off the electrocardiograph machine and disconnect off the subject.
  11. Clean off the jelly applied on the subject with water and dry with cotton wool or tissue.

Results

Analysis of Results

Note: Attached is a tracing of a normal 12 lead electrocardiogram (ECG) and the relationship of the events of the cardiac cycle to the waves and intervals of the normal left ventricular surfaces complex. Use these to help you analyze your recorded ECG.

Conclusion

Recommendation / Suggestions

Discussion Questions

1. What is the significance of:

  • i. P wave:
  • ii. QRS complex:
  • iii. T wave:

2. Why is P wave usually largest in standard lead II?

3. Why is T wave small or absent in lead aVL?

4. What is the significance of the interval between the end of P wave and the beginning of the QRS complex?

5. What factors influence the duration of the:

i. P-R interval:

ii. Q-T interval:

Reference: A Normal 12-Lead Electrocardiogram Layout

I
aVR
V1
V4
II
aVL
V2
V5
III
aVF
V3
V6
Physiology Steeplechase: ECG Interpretation

ECG Steeplechase

Experiment: Electrocardiography

Must Know:

  • Waves: P (Atrial), QRS (Ventricular), T (Repolarization).
  • Calculations: 300 / Big Squares = Rate.
  • Placement: V4 is at the Apex (5th ICS, Mid-Clavicular).
  • Pathology: ST Elevation = Infarction.
RED BLOOD CELL COUNT

RED BLOOD CELL COUNT

by with No Comment Physiology

RED BLOOD CELL COUNT & WBC COUNT

DETERMINATION OF RED BLOOD CELL COUNT

Principle

The methods generally used are based on the estimation of the number of cells in a small volume of diluted blood. The counting is carried out in a glass counting chamber. The volume of the fluid over each square is calculated from the area of a square and the depth of the fluid layer over it.

Core Concept: The average number of cells lying on one square is found from the counts of a series of squares. The product of this average number by the dilution gives the average number of cells in the undiluted blood.

Aim: To enumerate the number of RBCs per cubic millimeter of blood.

Student Objectives

After completion of this experiment, you should be able to:

  • Describe the relevance determining the red cell count.
  • Identify the different equipment and reagents used in this experiment.
  • List the normal red cell count in different age groups.
  • Outline the common physiological and pathological conditions that cause an increase or decrease in the red cell count.

Materials and Apparatus

1. RBC Diluting Pipette

Specifications:
  • Bulb type.
  • Graduated to give a dilution of 1 in 100 or 1 in 200.
  • Stem Markings: 0.5 and 1.0.
  • Upper Line: 101 (immediately above the bulb).

Red Bead: Located in the bulb to facilitate mixing of the blood and diluting fluid.

2. Hayem’s Fluid (Diluting Fluid)

Properties:

Must be isotonic; causes neither hemolysis nor crenation. Contains a fixative to preserve shape and prevent autolysis. Prevents agglutination/rouleaux.

Composition (per 200ml)
  • NaCl (3.8%): 1.0 g
  • Sodium Sulfate (Na₂SO₄): 5.0 g
  • Mercuric Chloride (HgCl₂): 0.5 g
  • Distilled Water: 200 ml
Function of Ingredients
  • NaCl & Na₂SO₄: Provide isotonicity (prevents shape change) and anticoagulant properties (prevents rouleaux).
  • Mercuric Chloride: Fixative, antifungal, and antimicrobial agent.

3. Neubauer Haemocytometer

Consists of a thick glass slide with a central platform 0.1mm lower than the side platforms (Depth of chamber = 0.1mm).

The Ruled Area (Center):
  • Divided into 16 medium sized squares.
  • Each medium square is subdivided into 16 small squares.
  • Area of smallest square = 1/400 sq. mm.
  • Counting Area: The red cells lying in 5 of the medium squares (E1, E2, E3, E4, and E5) are counted.

NB: For use, the haemocytometer as well as the diluting pipette must be clean, dry and absolutely grease free.

Procedure

  1. Sampling: Fill the pipette up to mark 0.5 on the scale with blood from the finger tip.
  2. Diluting: Wipe the outside of the pipette. Draw Hayem's fluid up to mark 101. Close the tip, detach sucker, and mix well (shaking 3-4 mins).
  3. Chamber Prep: Place coverslip on counting chamber. Apply gentle pressure until Newton rings (rainbow colors) appear.
  4. Discarding: Discard the first few drops (they contain no cells).
  5. Charging: Fill the chamber by holding the pipette tip against the edge of the coverslip. Do not overfill into troughs.
  6. Settling: Allow several minutes for cells to settle.
  7. Counting: Count red cells in 80 small squares (5 groups of 16 squares: E1-E5).
    Rule: Include cells touching top and right border lines only.

CALCULATION

Dimensions

Area of 1 small square = 1/400 sq mm

Depth of chamber = 1/10 mm

Volume of 1 square = 1/4000 cu mm

Variables

N = Total cells counted in 80 squares

Dilution Factor = 200

Squares Counted = 80

Final Formula (Cells per cu mm):

Total = N × 10,000

Derivation: (N × 4000 × 200) / 80

QUESTIONS

  1. When blood is taken to the mark 0.5 and diluent to mark 101, why is the dilution 1 in 200 and not 1 in 202?
  2. Why is blood diluted 200 times for red cell count?
  3. What is the function of the bead in the bulb?
  4. If Hayem’s solution is not available, can you use any other?
  5. How will you differentiate red cells from dust particles?
  6. What is the fate of leukocytes in this experiment?
  7. Since the mature red cells do not contain ‘nuclei’, are they dead cells? Explain your answer.
  8. Explain the possible errors that could arise in obtaining and diluting blood, due to uneven distribution of cells in the counting chamber, due to mechanical causes and from other sources.

DETERMINATION OF THE DIFFERENTIAL WHITE BLOOD CELL COUNT

Student Objectives

At the end of this experiment, you should be able to:

  • Identify all equipment and reagents used in the determination of the differential WBC count.
  • Describe the relevance and importance of preparing and staining a blood smear and doing a differential leukocyte count.
  • Prepare satisfactory blood films, fix and stain them and describe the features of a well stained film.
  • Identify different blood cells in a film and indicate the identifying features of each type of leukocyte.
  • Differentiate between neutrophils, eosinophils, basophils, monocytes, and lymphocytes.
  • Describe the functions of each type of the different leukocytes.
  • Outline the conditions in which the leukocyte numbers increase or decrease.

Relevance & Principle

Relevance:

Many hematological and other disorders can be diagnosed by a careful examination of a stained blood film. A physician may order a differential leukocyte count (always along with the total leukocyte count) to differentiate between the different causes of infection (e.g. bacterial vs. viral causes) depending on which sub-category of leukocyte is greatly affected. The differential leukocyte count is also done to monitor blood diseases like leukemia, or to detect allergic or parasitic infection.

Principle:

A blood film is stained with Leishman’s stain and scanned under oil immersion, from one end to the other. As each WBC is encountered, it is identified until 100 leukocytes have been examined. The percentage distribution of each type of WBC is then calculated.

Procedure

  1. Wipe the punctured finger with a piece of cotton wool soaked in alcohol, and allow a fresh drop of blood to accumulate.
  2. Hold a clean, dry microscope slide between the thumb and forefinger of the left hand. The slide is held by the corners of its right hand end so that its length extends at an approximate angle of 45 degrees above the left thumb and forefinger.
  3. Rotate the left hand inward, and touch the former upper surface of the slide to the drop of blood on the subject’s finger. A small drop of blood should be deposited onto the center of the slide about 1/3 of the length from the end held by the fingers of the left hand.
  4. Rotate the left hand outward until the surface of the slide with the deposited blood is uppermost and horizontal.
  5. A second clean, dry slide is held near its right hand end by the thumb and forefinger of the right hand. The free end should extend downward and to the left (away from the thumb and forefinger of the right hand). The edge of the lower end of this slide is brought onto contact with the slide held by the left hand at an angle of 45 degrees. The site of contact should be just ahead of the blood drop.
  6. The right hand slide (the spreader) is pulled back so that the edge on the inner side of the angle formed between the two slides just touches the blood drop. Capillarity at the inner apex of this 45 degrees angle distributes blood evenly across the width of the slides.
  7. A smooth, fairly fast sliding motion of the spreader (maintaining the 45 degrees angle of contact) along the length of the horizontal slide, deposits a thin, uniform film of blood. Several trials should produce an acceptable blood smear for staining.
  8. The slides which are to be stained are then laid smear side up on a staining and allowed to air dry.
  9. When the thin film of blood has air dried, Wright’s or Leishman’s stain is dripped from a dropping bottle onto the slide. The entire surface is covered until the stain is standing up from the edges of the glass but not running off the sides.
  10. The stain is allowed to stand on the slide from 1 to 3 minutes. The actual period of time depends upon the properties of each different batch of stain. Next, an equal volume of buffer solution should be added to the dye on the slide. If the buffer is dripped onto the dye, the entire fluid volume stands up from the edge of the slide without spilling.
  11. The buffer and stain are mixed by blowing lightly on the slide. A glossy sheen soon appears on the surface of the mixed liquid, which is allowed to remain on the slide for 4 to 5 minutes.
  12. Then the slide is flushed by flooding with distilled water or by holding one end of the slide horizontally under a slow stream of tap water. After the slide is well washed, place it in a slightly inclined position to drain and air dry.
  13. When the slide is dry, examine it first under the 4mm objective of the microscope to note the distribution of leukocytes. Since the distribution is often quite uneven and large leukocytes are carried to the edges of the smear, the differential count should sample the entire smear.
  14. The oil immersion objective of the microscope is required to identify the white cell types. Each white cell, as it is identified, is entered by a tally mark in the appropriate space on the data sheet.
  15. Proceed till 100 cells are counted, no cell will be seen twice in this way.
  16. Record the percent contributed to the total by each of the white cell types.
  17. After completion of the white count, observe the red cells on the slide. Record their shapes, sizes and color.

Focusing under Oil-Immersion Lens

  1. Examine the appearance of the slide for the general quality of staining. A good smear is roughly rectangular with a rather dense and straight ‘head end’ and a thinner and convex ‘tail end’. It is light purplish in color and translucent.
  2. Focus under the lowest power in the microscope and inspect the slide quickly for the distribution and appearance of the cells.
  3. Focus under the high power (40) and inspect the different areas of the smear. First distinguish between the numerous pink-colored red blood cells and the fewer large blue stained white blood cells.
  4. Then observe the distribution and appearance of the cells in different parts of the slide. At the head end the red cells are crowded and the white cells are poorly stained. At the extreme tail the cells are wide apart and white cells are distorted. The cells are stained well and seen clearly in the body of the smear near the tail end. Identify the best area (the body of the smear) for further study.
  5. The detail structure of the individual cells can only be seen through the oil immersion objective (magnification 100). Utmost care is needed when focusing under this objective as the focal distance is less than 2mm. Lower the stage of the microscope further down and switch on (turn) the oil immersion objective to position while watching the stage and the slide to avoid any damage. If the objective lens is likely to touch the slide, lower the stage further down.
  6. Place a drop of immersion oil on the blood smear and move the slide so that the oil (immersion oil) on the blood smear is directly under the objective. While watching the slide and the objective from the side and NOT through the eye-piece of the microscope, raise the stage until the oil touches the objective.
  7. Now look through the eye-piece and adjust the illumination (bright light is needed for clear vision). Looking through the eye-piece, raise the stage slowly until suddenly the cells come under focus. If clear image has not appeared within two or three turns of the knob, lower the stage and start focusing once again after ensuring that the illumination is adequate and that the slide contains cells (sometimes if the fixation was not properly done or if the slide was washed vigorously, the cells may be washed away. The slide may also be upside down). The oil between the objective and the slide serves as a concave lens to increase magnification and reduces aberration of light and facilitates the entry of all light into the microscope.
  8. Keep the cells under focus (by constant adjustment of the knob because the slightest alteration in the depth can affect the image) and move the slide about and study the structure of various types of cells and their size in relation to red cells.
  9. The red cells can be easily identified because they are pink non-nucleated discs found all over the field.
  10. You have to search for the white cells which will be seen as distinct cells with nucleus stained purple with clear or granulated cytoplasm. Remember that the cells are spheres and at any time the microscope will be focused only in one plane of the cell. Therefore, it will be necessary to adjust the focus up and down to see the cell in full.

Identification of Leucocytes

Note the following points with regard to any leucocyte:

  • The size and shape of the nucleus.
  • Presence or absence of cytoplasmic granules.
  • When present- the size, number and staining reaction of the granules.

a) If the nucleus occupies only a small portion of the cell and it is lobulated, the cell is a polymorpho-nuclear leucocyte.

b) If there are three more clear lobes then the cell may be Neutrophil; if the lobes are clearly defined and arranged like spectacles then it is probably an eosinophil; but if the two lobes lie on top of each other because of the position of the cell, only one small lobe can be seen. The nucleus of the basophil is elongated and poorly divided into three lobes.

c) If the nucleus is not lobulated but spherical and fills almost all the cell then the cell is a lymphocyte.

d) If the cell has a large kidney shaped nucleus, it is a monocyte; the nucleus of the monocyte can appear circular or even oval shaped depending on the orientation of the cell on the slide.

e) If cytoplasm is clear and light purplish in color, the cell is an agranulocyte.

f) If there is only scanty cytoplasm then the cell is a lymphocyte. Lymphocytes can be found is sizes equal to red cells (small lymphocytes) or much larger than the red cells (large lymphocyte).

Table 1: Appearance of White Blood Corpuscles in a Stained Blood Film

Cell type Diameter (μm) Nucleus Cytoplasm Cytoplasmic granules
Granulocytes
Neutrophils
(40-70%)		 10-14
(1.5-2X a RBC)		 Blue-violet
2-5 lobes, connected by chromatin threads
Seen clearly through cytoplasm		 Slate-blue in color Fine, closely-packed violet pink
Not seen separately
Give ground-glass appearance
Do not cover nucleus
Eosinophils
(1-6%)		 10-15 Blue-violet
2-3 lobes, often bi-lobed, lobes connected by thick or thin chromatin band
Seen clearly through cytoplasm		 Eosinophilic
Light pink-red		 Granular
Large, coarse
Uniform-sized
Brick-red to orange
Seen separately
Do not cover nucleus
Basophils
(0-1%)		 10-15 Blue-violet
Irregular shape, may be S-shaped, rarely bilobed
Not clearly seen, because overlaid with granules		 Basophilic
Bluish		 Granular
Large, very coarse
Variable-sized
Deep purple
Seen separately
Completely fill the cell, and cover the nucleus
Agranulocytes
Monocytes
(5-10%)		 12-20
(1.5-3 X a RBC)		 Pale blue-violet
Large single
May be indented horse-shoe, or kidney shaped (can appear oval or round, if seen from the side)		 Abundant
‘Frosty’
Slate-blue		 Amount may be larger than that of nucleus
No visible granules
Small Lymphocytes
(20-40%)		 7-9 Deep blue-violet
Single, large, round, almost fills cell.
Condensed, lumpy chromatin, gives ‘ink-spot’ appearance		 Hardly visible
Thin crescent of clear, light blue cytoplasm		 No visible granules
Large Lymphocytes
(5-10%)		 10-15 Deep blue-violet
Single, large, round or oval, almost fills cell
May be central or eccentric		 Large, crescent of clear, light blue cytoplasm
Amount larger than in small lymphocyte		 No visible granules

Exercise

Draw each type of the white blood cell as you see in the microscope and label them.

Neutrophil Drawing Area
Eosinophil Drawing Area
Basophil Drawing Area
Monocyte Drawing Area
Lymphocyte Drawing Area

RED BLOOD CELL MORPHOLOGY

Student Objectives

  • Identify various cell morphologies in relation to size, shape, and colour.
  • Identify normal RBCs and indicate their identifying features.
  • Identify abnormal RBCs and indicate the identifying features of each.
  • Discuss the conditions involved in each of RBC abnormalities.

Introduction

Usually, only normal, mature or nearly mature cells are released into the bloodstream, but certain circumstances can induce the bone marrow to release immature and/or abnormal cells into the circulation. When a significant number or type of abnormal cells are present, it can suggest a disease or condition and prompt a health practitioner to do further testing.

Characteristics of Normal RBCs (Normocytes):
  • Size: Uniform, 7 - 8 μm in diameter.
  • Nucleus: Absent (anucleated).
  • Shape: Round, biconcave discs (flattened like a donut with a depression in the middle).
  • Color: Pink to red with a pale center (central pallor).
  • Terminology: Often reported as normochromic and normocytic.

Aim: To study the colour and different morphologies of red blood cells in a stained film.

Procedure

Use a stained film (from the previous procedure) and study:

  • Shape and Size: Note the moderate variation in size around the diameter of about 7.5 μm.
  • Staining: Note the size of the central pallor (it normally occupies the central third) and compare the depth of colour in different cells. Look out for any granules in some cells.

Abnormal Red Blood Cells

1. Characteristics Related to Size

Term Morphology Description
Anisocytosis An increase in the variability of red cell size.
Microcytosis Decrease in the red cell size. Smaller than ± 7 μm.
Comparison: The nucleus of a small lymphocyte (± 8 μm) is a useful guide.
Macrocytosis Increase in the size of a red cell. Larger than 9 μm. May be round or oval.

2. Characteristics Related to Color

Term Morphology Description
Hypochromia Increase in the central pallor, occupying more than the normal third of the red cell diameter.
Hyperchromia Decrease in the central pallor and more dense staining.
Polychromasia Red cells stain shades of blue-gray. Due to uptake of both eosin (Hb) and basic dyes (residual ribosomal RNA). Often slightly larger (round macrocytosis).

3. Characteristics Related to Shape

Term Morphology Description
Poikilocytosis General term referring to an increase in abnormal red blood cells of any shape.
Acanthocytes Spherical cells with 2 - 20 spicules of unequal length, distributed unevenly over the surface.
Spherocytosis Red cells are more spherical. Lack the central area of pallor on a stained blood film.
Schistocytosis Fragmentation of the red cells.
Sickle Cells Sickle shaped (crescent) red cells.
Elliptocytosis Red cells are oval or elliptical. Long axis is twice the short axis.

EXERCISE

Draw the type of red blood cell as you see in the microscope and label them here.

DISCUSSION

1. Differential Count Analysis
  • Describe the possible errors in the determination of the differential count.
  • Describe the importance of total white cell count in interpreting the differential count.
  • Describe the importance of the Differential White cell count in clinical practice.
2. RBC Abnormalities

Discuss the different conditions related to the abnormalities of size, shape, and colour of red blood cells.

Physiology Steeplechase: Blood Cell Count

Blood Cell Steeplechase

Hemocytometry & WBC Differential

What to master:

  • Pipettes: RBC (Red bead) vs WBC (White bead).
  • The Grid: Where do you count RBCs vs WBCs?
  • WBC ID: Distinguish Eosinophils (Red granules) from Lymphocytes (Round nucleus).
  • Morphology: Sickle cells and Anisocytosis.
BLOOD TYPING

BLOOD TYPING & CROSSMATCHING

by with No Comment Physiology

BLOOD TYPING & CROSSMATCHING

BLOOD TYPING & CROSSMATCHING


EXPERIMENT : BLOOD TYPING

This experiment is a collection of measurements routinely carried out in hospital laboratories. The method chosen in the hospital will be a compromise between available instruments and wanted accuracy. Here we want you to get familiar with some of the most commonly used methods in this country.

Student Objectives

At the end of the experiment, you should be able to:

  • Identify the different equipment and reagents used in this experiment stating the relevance of each.
  • Define the terms blood “groups” and “blood types”, and name the various blood grouping systems.
  • Describe the physiological basis of blood grouping and state its clinical significance.
  • Explain the basis of the terms “universal donor” and “universal recipient”.
  • Describe the significance of Rh factor determination.
  • Determine blood groups by using commercially available anti-sera, and precautions to be observed.
  • Explain how blood is screened and stored in blood banks, and outline the changes that occur when blood is stored.
  • List the indications for blood transfusion.
  • Explain the relevance of matching donor and recipient blood groups before transfusion.

Blood Groups / Types

The membrane of each red blood cell contains millions of antigens that are ignored by the immune system. However, when patients receive blood transfusions, their immune systems will attack any donor red blood cells that contain antigens that differ from their self-antigens. Therefore, ensuring that the antigens of transfused red blood cells match those of the patient’s red blood cells is essential for a safe blood transfusion.

The most common and relevant of these antigens are the 3 antigens that form the ABO blood group system and Rhesus antigens that make up the Rhesus blood group. The presence of the three ABO agglutinogens (determined by three allelic genes) residing on the surface of red blood cells and the presence in the serum of three specific antibodies (agglutinins) to these genetically determined antigens is responsible for the major blood group antigen-antibody reactions, which may occur as a result of blood transfusions.

Genotypes & Phenotypes

Six genotypes in the ABO blood grouping system may exist:

Genotype OO

Group O

Genotype AA, AO

Group A

Genotype BB, BO

Group B

Genotype AB

Group AB

Note: A and B are dominant over the gene O. Therefore, genotype BO cannot be serologically distinguished from BB, and AO cannot be serologically distinguished from AA.

In addition, there exists other less common blood grouping systems like: the Duffy, Kell, Diego, Kidd, and MNS blood groups among others. This practical session however will focus on the ABO and Rhesus blood grouping systems since they are the most assessed clinically in hospital, and contribute the major bulk of blood transfusion reactions.

Principle

Landsteiner’s Law

States that if a particular antigen is present in the red blood cells, the corresponding antibody must be absent in the serum. If the particular antigen is absent in the red blood cells the corresponding antibody must be present in the serum.

Blood typing is performed on the basis of agglutination. Agglutination occurs if an antigen is mixed with its corresponding antibody.

Instructions

The normal procedure is to mix the unknown cells with two known sera containing A or B agglutinogens. You are provided with unknown red blood cells and a series of known sera samples.

Later in the practical, you will be required to obtain samples of your own (or your friends) blood by cleaning the fourth fingertip with alcohol and puncturing it with a sterile blood lancet. This has a shoulder that prevents too deep entry; therefore a sharp stab with the lancet gives a better blood supply, than a tiny prick.

Group Tasks:

  1. Typing of unknown red blood cells.
  2. Typing of own blood both ABO and Rh.
  3. Cross-matching of incompatible bloods.

Procedures

1. ABO Blood Grouping

  1. Label a series of grooves on a tile: Anti A, Anti B, Anti AB, and Control. Divide it into two halves with a grease pencil for blood sample X (known) and Y (unknown).
  2. Place one drop of serum in each groove with a glass rod. Repeat for each sample, taking care to wash and dry the rod between samples.
  3. Prepare a control groove using 0.9% saline instead of serum.
  4. Using one end of the glass rod mix the blood in the sera in each trough thoroughly for 30 seconds.
  5. Stir for 2 minutes and observe for agglutination.
  6. Record your findings and determine the group of the unknown blood and own blood used.

Observation: Agglutination may be visible to the naked eye as microscopic clumps like cayenne pepper grains or will be seen as smaller clumps under the microscope. The control will appear unaltered at the end of fifteen minutes when a final inspection should be made.

2. Rh Blood Grouping

  1. Follow steps 1-6 of the ABO system above using the Anti-D sera.
  2. Examine for evidence of agglutination.
  3. If agglutination did not occur within 2 minutes, record the blood as Rh negative.
  4. If agglutination occurred within 2 minutes, record the blood as Rh positive.

OBSERVATIONS

Name/ID Anti-A Anti-B Anti-AB Rh (Anti-D) Blood Group
Sample X
Sample Y
Own Blood

Note: Mark (+) for agglutination and (-) for no agglutination.

EXPERIMENT : CROSS-MATCHING

This experiment is designed to imitate the conditions appertaining to a transfusion of incompatible blood. Re-group partners so that incompatible bloods work together. Call one the ‘donor’ and the other the ‘recipient’.

Principle

  • The Reaction: Place on a slide one drop of a 1/10 dilution of ‘donor’ blood in citrate-saline. Add 1 drop of undiluted ‘recipient’ blood and mix immediately.
  • Observation: The donor’s cells are outnumbered ten to one by the recipient’s but are observed clumped together in small groups. The recipient’s cells float freely in the plasma in which the donor’s agglutinins are diluted twenty times.
  • Universal Donor Concept: That such a dilution of agglutinins fails to affect the recipient’s cells is the basis for the use of Group O blood for transfusion into any recipient in an emergency. Group O is thus sometimes called the ‘universal donor’.
Warning: The titer of A and B agglutinins may occasionally be sufficiently high to cause a reaction and the universal donor is never used if correct matching can be carried out.

Apparatus

  • Blood slide
  • Citrate saline (3.8%)
  • Watch glasses
  • White tile
  • White cell pipette
  • Cotton wool
  • Blood Samples (X & Y)

Procedure

  1. Preparation: Mark watch glasses X and another C for citrate saline.
  2. Dispense Fluids: Pipette blood from container X and put a drop on the watch glass marked X. Pour citrate saline in the watch glass marked C.
  3. Pipetting Blood: Using the white blood cell pipette, pipette blood up to the 1 mark from the watch glass (X).
  4. Dilution: Dilute it with citrate saline up to the 11 mark from the citrate saline watch glass and mix.
  5. Transfer Diluted Sample: Empty the diluted sample X from the white blood cell pipette into the trough of the white tile.
  6. Add Recipient Blood: Add one drop of blood sample from the container bottle marked Y using a glass rod into the trough containing the diluted blood X.
  7. Mixing: Wipe the glass rod and mix undiluted using a tooth pick for seconds.
  8. Observation: Observe the reactions and record your results.

DISCUSSION

1. Landsteiner's Law

What is Landsteiner’s law and what are the exceptions to this law?

2. Universal Donors/Recipients

What do you mean by a universal donor and a universal recipient?

3. Direct Testing

Explain the need for direct testing (cross-matching) before blood transfusion.

4. Storage Changes

What are the physiological changes that occur to RBC during storage?

5. Clinical Applications

Describe the importance of grouping the blood of pregnant women.

Describe the use of blood groups in medico-legal procedures.

Physiology Steeplechase: Blood Typing

Blood Group Steeplechase

ABO & Rhesus Grouping Experiment

Exam Strategy:

  • Clumps = Positive: If it clumps in 'A', it is 'A'.
  • No Clumps = O: If nothing clumps (except maybe Rh), it is 'O'.
  • Reagent Colors: Blue is A, Yellow is B.
  • Genetics: Know who can donate to whom.
HAEMATOLOGICAL INDICES

HAEMATOLOGICAL INDICES

by with No Comment Physiology

HAEMATOLOGICAL INDICES - PCV, MCV, MCH

HAEMATOLOGICAL INDICES: PCV ESTIMATION

Student Objectives (PCV Experiment)

At the end of this experiment, you should be able to:

  • Identify all equipment and reagents used in the determination of PCV.
  • Define hematocrit, and explain its clinical significance.
  • Briefly describe physiological/pathological factors that cause decrease PCV.
  • List the possible sources of error in the determination of PCV.

Instruments & Reagents

For Venous Blood

  • Wintrobe tube
  • Pasteur pipette
  • Centrifuge
  • Anticoagulant: Potassium Oxalate crystals (EDTA can also be used)

For Capillary Blood

  • Heparinized capillary tubes
  • Micro-centrifuge

Procedure for Venous Blood PCV

Using Wintrobe Method

  1. Blood Collection: Perform venipuncture to collect blood into a tube with a pinch of oxalate crystals mixture.
  2. Mixing: Mix the blood with anticoagulant by rolling the tube between the palms of both hands.
  3. Transfer: Draw blood into a Pasteur pipette and introduce it into the Wintrobe tube.
  4. Wintrobe Tube Details:
    • Special centrifuge tube with uniform diameter throughout.
    • Holds about 1 ml of blood.
    • Graduations are scaled in reversed directions on each side so either plasma or cell volume can be read.
  5. Filling: Fill the Wintrobe tube with blood from a fine teat pipette up to the 100 mark (equivalent to 100%).
  6. Centrifugation: Centrifuge the tube.
  7. Reading: Read the PCV as a percentage of the total volume.

Procedure for Capillary Blood PCV

Using Microhematocrit Method

  1. Labeling: Using labeling paper, mark two micro capillary tubes as X and Y.
  2. Blood Sample: Place blood into watch glass X.
  3. Tube Filling:
    • Dip one end of tube X into the blood at an angle.
    • Allow tube to fill to 3/4 full by capillary attraction.
  4. Sealing:
    • Close the open end with index finger.
    • Lift tube off the blood and seal the end with plasticine wax.
    • Open the tip to remove excess wax.
  5. Centrifuge Setup:
    • Open micro centrifuge lid and unscrew top to expose segment carrier.
    • Fix micro capillary tubes (sealed end first) in segments X and Y.
  6. Centrifugation:
    • Close lid and start centrifuge.
    • Centrifuge for 5 minutes.
    • Gradually increase speed to 10,000 rpm.
  7. Reading:
    • Remove segments and place into micro hematocrit reader.
    • Position tube so total blood column reads from 0% to 100%.
    • Place movable arm so line cuts the interface between cells and plasma.
    • Record results in % volumes.

RESULTS

Measurements
PCV of Male:
PCV of Female:
Thickness of Buffy Coat:
Components Separated
Plasma (Top)
Buffy Coat (Middle)
Red Cells (Bottom)

DISCUSSION TOPICS

  • Comparison of both methods: Discuss the differences, advantages, and disadvantages between Venous (Wintrobe) vs Capillary (Microhematocrit) methods.
  • Clinical Application: Describe the use of PCV (Packed Cell Volume) in clinical practice.

CLINICAL SIGNIFICANCE OF ABSOLUTE CORPUSCULAR VALUES

Knowledge of hemoglobin level, RBC count, and PCV (Hematocrit) alone does not provide information about:

  • Average red blood cell volume.
  • Hb content per cell.
  • Percentage saturation with hemoglobin.

These parameters are crucial for diagnosing anemia types. While not obtainable directly through experimental methods, they can be calculated from three basic values: Hemoglobin (Hb), RBC count, and PCV.

Student Objectives (Corpuscular Values)

  • Explain the clinical significance of calculating absolute corpuscular values.
  • Describe the macro-corpuscular values and different formulas used in calculations.
  • Describe the classification of anemia based on hematological indices.

Calculations & Formulas

Required Basic Measurements: 1. Hb (g/100ml)
2. RBC count (×10⁶ cells/mm³)
3. PCV (% per 100ml blood)

1. Mean Corpuscular Volume (MCV)

Definition: Average volume of a single red blood cell, expressed in femtoliters (fl).

Formula:

MCV = (PCV × 10) / RBC count

OR: MCV = PCV per liter / RBC (10¹²/L)

Normal Range: 74 - 95 femtolitres

2. Mean Corpuscular Hemoglobin (MCH)

Definition: Average hemoglobin content (weight) in a single red blood cell, expressed in picograms (pg).

Clinical Use: Basis for classifying anemia into hypochromic, normochromic, and hyperchromic types.

Formula:

MCH = (Hb in g/100ml) / RBC count

(RBC count in million/mm³)

Normal Range: 27 - 32 pg

3. Mean Corpuscular Hemoglobin Concentration (MCHC)

Definition: Relationship between hemoglobin and volume in red blood cells, expressed as percentage saturation of cells with Hb (not whole blood).

Key Principle: RBCs cannot exceed ~36% Hb concentration due to limitations in Hb synthesizing machinery.
Formula:

MCHC = (Hb × 100) / PCV

Normal Range: 30 - 36%

Other Hematological Indices (for further reading):
  • Mean Corpuscular Diameter (MCD)
  • Color Index (CI)

QUESTIONS

1. Reliability

Giving a reason, state which of the corpuscular values (MCV, MCH or MCHC) is most reliable and useful clinically?

2. Physiological Limits

Why can't RBCs be filled beyond 36% with Hb?

3. Classification

How can you classify anemias on the basis of MCV and MCH?

Hematology Steeplechase: Hb, PCV & Indices

Hematology Steeplechase

Hb Estimation, PCV & Clinical Indices

Exam Focus:

  • Calculations: Know your formulas for MCV, MCH, and MCHC.
  • Equipment: Identify Sahli's vs. Wintrobe's tubes.
  • Layers: Locate the Buffy Coat.
  • Principles: Acid Hematin vs. Cyanmethemoglobin.
TOAD HEART IN SITU AND PROPERTIES OF CARDIAC MUSCLE

TOAD HEART IN SITU AND PROPERTIES OF CARDIAC MUSCLE

by with No Comment Physiology

TOAD HEART IN SITU & PROPERTIES OF CARDIAC MUSCLE

EXPERIMENT 1: TOAD HEART IN SITU AND PROPERTIES OF CARDIAC MUSCLE

Objectives

  • Describe the method of isolation of the toad heart.
  • Determine the effect of temperature on cardiac muscle.
  • List the effect of different ions and drugs on the isolated heart muscle.
  • Explain the mechanism of action of drugs and ions on the cardiac muscle.
  • List the properties of the cardiac muscle.
  • Elaborate the physiological basis of different properties of the cardiac muscle.

Introduction

The naturally beating toad heart is first observed in situ with its apex connected to a writing lever for recording the sequence of events during contraction. The heart rate is altered by changing the temperature of the bathing fluid. Electrical stimuli are applied between beats to illustrate properties of the conducting system of the heart.

Once the conducting system has been inactivated by crushing, cardiac muscle can be studied as a muscle preparation. Cardiac muscle has a different stimulus-response relationship from skeletal muscle, and it shows refractoriness to a second stimulus at some stimulus intervals.

Apparatus

Kymograph

A motor-driven rotating drum that operates at four different speeds, equipped with a clutch mechanism.

The drum carries smoked paper that is written on by various levers.

Note: Traces must be fully labeled including student names before being shelled.

Induction Coil

Provides either single stimuli or repetitive stimuli.

Note: Relative stimulus strength must always be recorded as the distance in centimeters between primary and secondary coils.

Preparation


A. Dissection

  1. Use a pithed toad (brain and spinal cord destroyed) placed on its back on a cork board.
  2. Pin through the web of each foot and the lower jaw.
  3. Expose the xiphisternum (cartilaginous extension of the sternum).
  4. Make a transverse incision through the abdominal wall below the xiphisternum.
  5. Cut through both sides of the sternum and pectoral girdle.
  6. Remove anterior thoracic wall.
CRITICAL:

Frequently irrigate tissues with physiological saline to prevent dessication (drying out).

  1. Display thoracic contents by repinning front feet wider apart.
  2. Carefully incise the pericardium laterally and reflect it back.
  3. Observe heart action and identify successive contractions of the sinus venosus, atria, ventricles, and truncus arteriosus.

B. Mounting for Recording

  1. Tie silk thread to a fine hook and pass through the ventricle tip without puncturing tissue.
  2. Gently lift heart and cut the transverse pericardial ligament (between atria and venous side).
  3. Transfer toad to recording stand bath.
  4. Anchor heart base with pin through connective tissue near the aorta.
  5. Keep heart moist with Ringer's solution but do not fill the bath yet.
WARNING:

Skin secretions are toxic—prevent bath fluid contamination.

  1. Tie silk thread to the hole nearest the heart lever pivot (must be precisely vertical).
  2. Adjust lever vertically so it's horizontal when heart is relaxed and thread is just taut.
  3. Adjust kymograph for maximum friction.
  4. Adjust lever spring for 1-2 cm amplitude tracing.

EXPERIMENTAL PROCEDURES


A. Heart Beat & Temperature Effects

1. Baseline Recording
  • Speed: Moderate (25 mm/sec).
  • Observation: Make a short record. Relate lever movements to actual heart chambers—identify up to four contractile events.
2. Temperature Effects (General)
  • Speed: Slow (2.5 mm/sec).
  • Temps: Bathe heart with saline at approx 0°C, 10°C, and 20°C.
  • Note: Ensure pipette is cooled/heated by solution. Measure temperature accurately. Use signal marker and clock for time traces.

Alternate Temperature Procedure

  1. Label beakers: 0°C, 10°C, 20°C, 30°C, 40°C.
  2. Add 3 mL frog Ringer's to each.
  3. Immerse muscle at 0°C, record twitch.
  4. Replace with 20°C and 30°C, wait 30 seconds, record.
  5. Replace with 10°C, wait 1 minute, record.
  6. Replace with 40°C, record irregular twitches.
  7. Analysis: Draw lines from curve summits to baseline. Record graph heights (cm) and durations.

Data Table 1: Heart Rate vs Temperature

Temperature (°C) Heart Rate (beats/min) Observations
0
10
20
30
40

B. Refractory Period of Conducting System

  • 1 Place Electrodes: One against auricles, other against ventricle. Note: Must not impede movement.
  • 2 Settings: Set signal marker in primary circuit for single break stimuli. Run drum at moderate speed (25 mm/sec).
  • 3 Stimulus Strength: Move secondary coil to produce supra-maximal stimuli (8-10 cm on scale).
  • 4 Procedure: Apply single stimuli at various times during the cardiac cycle (systole and diastole).
    • Measurement Required:

    Determine refractory period duration and maximum "compensatory pause".

    C. Mechanical Block of Conduction (Stannius Ligatures)

    Preparation:

    Pass moistened silk thread between aortae and veins, tie loosely. Record at slow speed (2.5 mm/sec).

    First Ligature (Sinus-Atrial)

    Tighten ligature across the sinus venosus-atrial junction (white crescent).

    Effect: Crushes conducting tissues to auricles; sinus continues beating alone while the rest of the heart may stop temporarily.

    Second Ligature (Atrio-Ventricular)

    Tie between atrium and ventricle across the atrioventricular bundle.

    Effect: Isolates the ventricles from the atria.
    Measurement Required:

    Determine the inherent rates of the auricles and ventricles separately after isolation.

    D. PROPERTIES OF CARDIAC MUSCLE

    1. Stimulus-Response Relationship

    1. Set secondary coil at maximum distance from primary coil.
    2. Apply single break stimuli to ventricle (both electrodes) at ~15-second intervals.
    3. Between stimuli, turn drum ~1 cm by hand to separate traces.
    4. Successively increase stimulus strength (move coils closer) until ventricle responds.
    5. Record cm position of secondary coil for each response.
    6. Find sub-threshold stimulus, then switch to repetitive stimulation.
    7. Observe response to brief repetitive stimulation.

    2. Refractory Period of Directly Stimulated Muscle

    1. Reconnect for single stimuli. Set supra-threshold stimulus strength.
    2. Run drum at moderate speed (25 mm/sec).
    3. Apply paired stimuli by two quick taps of telegraph key (< 1 second intervals).
    4. Measurement: Determine the maximum interval without a second contraction. This represents the refractory period.
    5. Repeat with increased stimulus strength (refractory period should shorten).
    6. Apply brief repetitive supra-threshold stimuli—compare response to single stimulus.

    E. EFFECT OF IONS ON HEART IN SITU

    Ion Effects Overview:
    • Isotonic NaCl: Rhythm disappears, beating ceases.
    • CaCl₂: Heart beats briefly, then stops in systole (contraction).
    • KCl: Heart stops in diastole (relaxation).
    • Ringer's solution (all three ions): Beating continues indefinitely.
    Ringer's Solution Composition: NaCl: 0.9 g
    CaCl₂: 0.024 g
    KCl: 0.042 g
    NaHCO₃: 0.02 g
    Distilled water to 100 mL

    Procedure

    1. Bathe heart with Ringer's until baseline rate established.
    2. Prepare NaCl, KCl, CaCl₂ at 3× concentration.
    3. Apply 5 mL of each solution onto heart.
    4. Application Order: NaCl → CaCl₂ → KCl.
    Critical:

    Wash thoroughly with Ringer's between each application. Ensure heart returns to baseline rate and rhythm before adding the next solution.

    Data Table 2: Ion Effects

    Substance Heart Rate / Observation
    Ringer's Solution
    Sodium Chloride
    Calcium Chloride
    Potassium Chloride

    F. EFFECT OF DRUGS ON HEART IN SITU

    Apply adrenaline and acetylcholine using the same procedure as ions (apply, observe, wash, recover).

    Data Table 3: Drug Effects

    Drug Heart Rate / Observation
    Adrenaline
    Acetylcholine

    ANALYSIS OF RESULTS

    A. Data Tables

    • Temperature Effects: Columns for measured temperature, logarithm of temperature, and heart rate (beats/min).
    • Stimulus-Response: Columns for applied stimulus (secondary coil position in cm) and muscle contraction (mm deflection).

    B. Graphs to Plot

    • HR vs Log Temp: Heart rate (ordinate/y-axis) against log of temperature (abscissa/x-axis).
    • Contraction vs Stimulus: Contraction (mm, ordinate) against stimulus strength (cm, abscissa). Note: Weakest stimulus at origin; abscissa scale decreases left to right.

    C. Calculations (Q₁₀)

    Calculate the temperature coefficient (Q₁₀):

    Q₁₀ = (Heart rate at higher temp) ÷ (Heart rate at lower temp)

    (For a 10°C rise)

    Compare Q₁₀ values for different temperature ranges (e.g., 0-10°C vs 10-20°C) and explain similarities/differences.

    QUESTIONS

    1. Temperature Analysis

    How did temperature (heat and cold) change the heart rate from baseline? Explain the physiological mechanism.

    2. Chemical Mechanisms

    Describe the effect that you would expect each chemical (Ions & Drugs) used to have on heart rate and amplitude, and explain your reasoning based on cardiac physiology.

    Physiology Steeplechase: Toad Heart In Situ

    Physiology Steeplechase

    Toad Heart & Cardiac Muscle Properties

    What to identify:

    • Apparatus: Identify the Kymograph and setup.
    • Tracings: Interpret the effect of Temperature, Ions, and Drugs on the graph.
    • Mechanisms: Explain why the curve changed (e.g., Systolic vs Diastolic arrest).
    The-steeplechase-exam-in-Human-Anatomy-practical-1-2048

    Anatomy steeplechase questions pdf

    by with No Comment Physiology

    Anatomy Steeplechase

    Anatomy Steeplechase: Embryology, Histology & Limbs

    Anatomy Steeplechase

    Embryology, Histology, Upper & Lower Limb

    Exam Rules:

    • Be Specific: Don't just identify the bone; identify the landmark.
    • Side Matters: In a real exam, always specify Left/Right.
    • Clinical Correlation: Think about nerve supplies and injuries.
    Respiratory Function Tests

    Respiratory Function Tests

    by with No Comment Physiology

    Respiratory Function Tests

    Respiratory Function Tests

    Respiratory Function Tests (RFTs), or lung function tests, are painless breathing evaluations measuring how well your lungs take in air, move it in and out, and transfer oxygen to blood, using tools like spirometry (how fast you breathe out) and plethysmography (total lung capacity in a booth) to diagnose breathing issues, monitor lung diseases, and assess lung health before surgery. These tests provide crucial data for managing asthma, COPD, and other respiratory conditions.

    Overall Objective

    To understand the principles, methodologies, and clinical significance of various tests used to assess pulmonary function, differentiate between obstructive and restrictive lung diseases, and monitor disease progression.

    Objective 1: Describe the principles and interpretation of spirometry, including FEV1, FVC, and FEV1/FVC ratio.

    Spirometry is the most common and fundamental pulmonary function test. It measures how much air a person can inhale and exhale, and how quickly they can exhale it. It's an indispensable tool for diagnosing and managing a wide range of respiratory conditions.

    A. Spirometry Basics

    Definition and Purpose

    • Definition: Spirometry is a simple, non-invasive test that measures the volume and flow of air that can be inhaled and exhaled.
    • Purpose:
      • Diagnose respiratory diseases (e.g., asthma, COPD).
      • Monitor disease progression and response to treatment.
      • Assess severity of lung impairment.
      • Evaluate disability for legal or insurance purposes.
      • Pre-operative assessment of respiratory risk.

    How Spirometry is Performed (Forced Exhalation Maneuver)

    1. The patient takes the deepest breath possible (maximal inspiration) to reach Total Lung Capacity (TLC).
    2. Then, they forcefully and rapidly exhale all the air they can, for as long as they can (at least 6 seconds, or until no more air can be exhaled) into a mouthpiece connected to a spirometer.
    3. It requires good patient cooperation and effort to obtain reliable and reproducible results.

    Parameters Measured

    Spirometry primarily measures two key volumes, from which a crucial ratio is derived:

    FVC

    Forced Vital Capacity (Total Volume Exhaled)

    • Definition: The total volume of air exhaled during a maximal forced expiration, starting from a maximal inspiration.
    • Represents: Total "usable" air. Reflects overall size/elasticity of lungs and chest wall.
    • Normal Value: ~4-6 liters (varies by age/height).
    FEV1

    Volume in 1st Second

    • Definition: The volume of air exhaled in the first second of the FVC maneuver.
    • Represents: Speed/ease of expulsion. Indicator of airway patency/resistance.
    • Normal Value: 75-85% of FVC.
    FEV1/FVC Ratio

    The Critical Ratio

    • Definition: Ratio of FEV1 to FVC, expressed as percentage.
    • Represents: Most important parameter for differentiating obstructive vs. restrictive disease.
    • Normal Value: ≥ 70-75% (or ratio ≥ 0.70-0.75).

    Flow-Volume Loops

    • Description: A graphical representation generated during spirometry that plots instantaneous expiratory flow rate (y-axis) against lung volume (x-axis).
    • Normal Loop: A rapid rise to peak expiratory flow, followed by a linear decrease in flow as lung volume decreases, forming a triangular or "sail-like" shape. Inspiratory limb is a smooth, concave curve.
    • Obstructive Pattern: Characterized by a "scooped-out" or concave shape of the expiratory limb, reflecting significant airflow limitation. Peak flow may be reduced.
    • Restrictive Pattern: Characterized by a "witch's hat" appearance – smaller loop overall (reduced FVC) but with a relatively normal, preserved flow rate shape (proportional but scaled down).
    • Fixed Airway Obstruction: Both inspiratory and expiratory limbs are flattened.

    B. Interpretation of Spirometry Results

    Interpretation involves comparing measured values to predicted normal values (based on age, sex, height, ethnicity).

    Normal

    • Ratio: ≥ 70-75%
    • FEV1: ≥ 80% predicted
    • FVC: ≥ 80% predicted
    • Suggests healthy lung function.

    Obstructive

    Example: COPD, Asthma

    • Ratio: < 70-75% (KEY DIAGNOSTIC)
    • FEV1: Reduced (< 80%)
    • FVC: Normal or slightly reduced
    • Loop: "Scooped-out"
    • Increased resistance makes exhalation difficult.

    Restrictive

    Example: Fibrosis, Scoliosis

    • Ratio: Normal/Increased (≥ 70%)
    • FEV1: Reduced (< 80%)
    • FVC: Reduced (< 80%)
    • Loop: "Witch's hat" (small)
    • Reduced compliance/volume; both reduced proportionally.

    Severity Grading (e.g., COPD GOLD)

    Based on FEV1 % predicted:

    • Mild: ≥ 80%
    • Moderate: 50-79%
    • Severe: 30-49%
    • Very Severe: < 30%

    Bronchodilator Reversibility

    • Purpose: Differentiate Asthma vs. COPD.
    • Significant Reversibility: Increase in FEV1/FVC of >12% AND >200 mL.
    • Asthma: Typically significant reversibility.
    • COPD: Often less pronounced/consistent; obstruction is largely fixed.

    Objective 2: Understand additional lung volumes and capacities measured by methods other than spirometry, particularly Residual Volume (RV) and Total Lung Capacity (TLC).

    While spirometry is excellent for measuring dynamic lung function (how much air can be quickly moved), it has limitations. Specifically, it cannot measure volumes of air that cannot be exhaled from the lungs. This necessitates other techniques to determine the complete picture of lung volumes.

    A. Limitations of Spirometry

    Spirometry directly measures vital capacity (VC or FVC) and its components (IRV, TV, ERV). However, it cannot measure:

    • Residual Volume (RV): The volume of air remaining in the lungs after a maximal forced expiration.
    • Functional Residual Capacity (FRC): The volume of air remaining in the lungs after a normal tidal expiration (ERV + RV).
    • Total Lung Capacity (TLC): The total volume of air in the lungs after a maximal inspiration (VC + RV, or FRC + IC).

    These volumes are essential for diagnosing and characterizing certain lung conditions, particularly restrictive lung diseases (where TLC is reduced) and obstructive diseases with air trapping (where RV and TLC might be increased).

    B. Methods for Measuring RV, FRC, and TLC

    Since RV, FRC, and TLC all include the residual volume, which cannot be exhaled, specialized techniques are required to measure them.

    1. Helium Dilution Method

    • Principle: Inert gas dilution. If a known quantity of a tracer gas (helium, insoluble in blood) is introduced into a closed system, it distributes throughout the available lung volume until equilibrium is reached. The extent of dilution is used to calculate the unknown volume.
    • Procedure:
      1. Patient connected to spirometer with known volume/concentration of helium (C1).
      2. Patient breathes normally (tidal breathing) from closed system. Exhales to FRC, then circuit opens.
      3. Helium mixes with air in lungs (FRC volume).
      4. Breathing continues until equilibrium is reached (C2). Usually 5-7 minutes.
      5. Patient performs maximal expiration (ERV) and maximal inspiration (VC).
    • Calculation:
      (Vspirometer * C1) = (Vspirometer + FRC) * C2
      FRC = ( (Vspirometer * C1) / C2 ) - Vspirometer
      Once FRC is known: TLC = FRC + IC and RV = FRC - ERV.
    • Limitations: Assumes free mixing. In severe obstruction/air trapping (e.g., emphysema), trapped air may not equilibrate, leading to underestimation of FRC and TLC.

    2. Nitrogen Washout Method

    • Principle: Uses inert gas (nitrogen) but measures washout. Lungs are normally ~80% nitrogen. Breathing 100% O2 washes nitrogen out, which is collected.
    • Procedure:
      1. Patient exhales to FRC.
      2. Breathes 100% oxygen from spirometer.
      3. Exhaled air (containing lung nitrogen) is collected and analyzed.
      4. Continues until exhaled nitrogen drops to < 1.5% (approx 7 mins).
    • Calculation:
      FRC = (Total N2 exhaled) / (Initial alveolar N2 conc, ~0.80)
    • Limitations: Similar to helium dilution, tends to underestimate FRC/TLC in severe obstruction due to poorly ventilated trapped air.

    3. Body Plethysmography (Body Box)

    • Principle: Generally considered the most accurate method. Uses Boyle's Law (P1V1 = P2V2).
    • Procedure:
      1. Patient sits in airtight "body box".
      2. Pants against a closed shutter at end of normal expiration (FRC).
      3. Chest expansion decreases box volume -> increases box pressure.
      4. Simultaneously lung volume increases -> lung pressure decreases.
      5. Transducers measure mouth pressure and box pressure changes.
    • Measurement & Advantages: Calculates thoracic gas volume (TGV). Unlike dilution methods, it measures all compressible gas within the thorax (including trapped air), making it more accurate for obstructive diseases.
    • Limitations: Claustrophobia, equipment cost.

    C. Clinical Significance of RV and TLC

    Increased RV & TLC

    • Indicates: Hyperinflation and air trapping.
    • Clinical Relevance: Hallmark of Obstructive Lung Diseases (Emphysema, Asthma).
    • Emphysema: Loss of elastic recoil = difficult to exhale = increased RV/FRC.
    • Asthma/Bronchitis: Airway narrowing traps air.
    • RV/TLC Ratio: An increased ratio (>30%) is a strong indicator of air trapping.

    Decreased RV & TLC

    • Indicates: Reduced lung volumes.
    • Clinical Relevance: Defining characteristic of Restrictive Lung Diseases.
    • Intrinsic: Fibrosis, Sarcoidosis (stiff tissue).
    • Extrinsic: Obesity, Neuromuscular disease, Scoliosis (restricted expansion).
    • Differentiation: A reduced TLC (<80% predicted) is the definitive criterion for restrictive disease.

    Objective 3: Explain the principles and clinical utility of Diffusing Capacity of the Lung for Carbon Monoxide (DLCO/TLCO).

    The diffusing capacity of the lung (DLCO), also sometimes referred to as Transfer factor for Carbon Monoxide (TLCO), measures the efficiency of gas exchange across the alveolar-capillary membrane. It assesses the integrity and function of the primary site where oxygen enters the blood and carbon dioxide leaves it.

    A. DLCO Basics

    • Definition: DLCO is the rate at which carbon monoxide (CO) is absorbed from the alveoli into the pulmonary capillary blood per unit of driving pressure (partial pressure gradient) for CO. Essentially, it quantifies the ability of the lungs to transfer gas from the inhaled air into the red blood cells.
    • Principle:
      • Tracer Gas (Carbon Monoxide): Used because of its very high affinity for hemoglobin (200-250x greater than oxygen). This ensures that almost all CO that diffuses into the blood binds to hemoglobin, maintaining a near-zero partial pressure in plasma. Thus, alveolar partial pressure (PACO) becomes the primary driving force.
      • Test Gas Mixture: Inhaled mixture contains low concentration CO (0.3%), an inert tracer gas (helium/methane for measuring alveolar volume), oxygen (21%), and nitrogen.
      • Measurement: Calculated by measuring how much CO disappears from the inhaled gas (after correcting for alveolar volume).
    • Correcting Factors:
      • Hemoglobin Concentration: Since CO binds to Hb, the amount of available Hb directly affects uptake. DLCO is corrected (upwards for anemia, downwards for polycythemia) to reflect normal Hb levels.
      • Alveolar Volume (VA): Total surface area is proportional to lung volume. DLCO/VA (KCO) normalizes diffusing capacity to lung volume, differentiating reduced DLCO due to small lungs vs. actual membrane impairment.

    B. Factors Affecting DLCO

    The diffusing capacity is determined by properties of the alveolar-capillary membrane and the pulmonary circulation.

    1. Surface Area:
      • Increased: Exercise, Polycythemia.
      • Decreased: Emphysema (destruction of alveolar walls), Pneumonectomy/Lobectomy.
    2. Membrane Thickness:
      • Decreased DLCO: Conditions increasing barrier thickness.
      • Pulmonary Fibrosis / ILD.
      • Pulmonary Edema (fluid accumulation).
      • Asbestosis, Sarcoidosis.
    3. Hemoglobin Concentration:
      • Decreased DLCO: Anemia (fewer binding sites).
      • Increased DLCO: Polycythemia (increased RBC mass).
    4. Pulmonary Capillary Volume:
      • Decreased: Pulmonary Hypertension, Pulmonary Embolism.
      • Increased: Congestive Heart Failure, Cardiac Shunts (L to R), Exercise.

    C. Interpretation of DLCO Results

    Results are compared to predicted values. < 80% predicted is typically considered reduced.

    Reduced DLCO

    • Reduced Surface Area:
      • Emphysema: Key differentiator from asthma.
      • Pneumonectomy.
    • Increased Thickness:
      • Fibrosis / ILDs: Correlates with severity.
      • Pulmonary Edema.
    • Reduced Capillary Vol:
      • Pulmonary Hypertension: Early sign.
      • Pulmonary Embolism.
    • Other:
      • Anemia (uncorrected).
      • Drug toxicity (Amiodarone).

    Normal DLCO

    • Asthma: Primarily airway obstruction, membrane intact. (Key vs Emphysema).
    • Chronic Bronchitis: Usually normal unless emphysema present.
    • Neuromuscular / Chest Wall: Membrane unaffected.

    Increased DLCO

    • Polycythemia: Increased Hb.
    • Congestive Heart Failure: Increased capillary volume.
    • Pulmonary Hemorrhage: CO binds to RBCs in alveoli.
    • Exercise: Capillary recruitment.

    D. Clinical Utility

    • Differentiating Lung Diseases:
      • Obstructive: Distinguishes Emphysema (Low DLCO) vs. Asthma/Bronchitis (Normal DLCO).
      • Restrictive: Distinguishes ILD (Low DLCO) vs. Neuromuscular/Chest Wall (Normal DLCO).
    • Other Uses:
      • Severity/Prognosis: Monitors progression in ILD/Emphysema.
      • Early Detection: Drug toxicity may show low DLCO before spirometry changes.
      • Pre-op: Surgical risk assessment.
      • Vascular Disease: Suggests PH or emboli if parenchyma is normal.

    Objective 4: Discuss the role of Arterial Blood Gas (ABG) analysis in assessing respiratory and acid-base status.

    Arterial Blood Gas (ABG) analysis is a vital diagnostic tool that measures the partial pressures of oxygen (PaO2) and carbon dioxide (PaCO2) in arterial blood, as well as blood pH and bicarbonate (HCO3-) concentration. It provides a real-time snapshot of the patient's oxygenation, ventilation, and acid-base balance.

    A. ABG Components

    The primary parameters measured or calculated from an ABG sample include:

    pH (7.35 - 7.45)
    • Definition: Measure of acidity/alkalinity (H+ concentration).
    • Significance: Acid-base imbalance. Acidosis (< 7.35), Alkalosis (> 7.45).
    PaO2 (80 - 100 mmHg)
    • Definition: Pressure of dissolved oxygen in arterial blood.
    • Significance: Oxygenation status. < 80 mmHg = Hypoxemia.
    PaCO2 (35 - 45 mmHg)
    • Definition: Pressure of dissolved CO2. Controlled by ventilation.
    • Significance:
      • > 45 mmHg: Hypoventilation (Resp. Acidosis)
      • < 35 mmHg: Hyperventilation (Resp. Alkalosis)
    HCO3- (22 - 26 mEq/L)
    • Definition: Bicarbonate (Metabolic component).
    • Significance:
      • < 22 mEq/L: Metabolic Acidosis
      • > 26 mEq/L: Metabolic Alkalosis

    SaO2 (Saturation): Normal: 95 - 100%. Percentage of hemoglobin binding sites saturated with oxygen.

    B. Interpretation of ABG Results

    Interpreting ABGs involves a systematic approach to identify the primary acid-base disturbance, assess for compensation, and evaluate oxygenation and ventilation.

    1. Acid-Base Disturbances

    Step Logic
    Step 1: pH Is it acidic (< 7.35), alkaline (> 7.45), or normal?
    Step 2: PaCO2 (Resp) Acidosis + High PaCO2 = Respiratory Acidosis
    Alkalosis + Low PaCO2 = Respiratory Alkalosis
    Step 3: HCO3- (Metabolic) Acidosis + Low HCO3- = Metabolic Acidosis
    Alkalosis + High HCO3- = Metabolic Alkalosis

    2. Compensation

    • Respiratory Compensation: Lungs adjust CO2 to correct metabolic issues.
      • Metabolic Acidosis: Hyperventilation (blow off CO2).
      • Metabolic Alkalosis: Hypoventilation (retain CO2).
    • Metabolic Compensation: Kidneys adjust HCO3- to correct respiratory issues.
      • Resp Acidosis: Retain HCO3-, excrete H+.
      • Resp Alkalosis: Excrete HCO3-, retain H+.
    • Partial vs. Full: If pH is abnormal but moving towards normal = Partial. If pH is back in range = Full.

    3. Oxygenation & Ventilation Status

    • Hypoxemia Grading (PaO2):
      • Mild: 60-79 mmHg
      • Moderate: 40-59 mmHg
      • Severe: < 40 mmHg
    • Ventilatory Status:
      • Hypoventilation: PaCO2 > 45 mmHg (Acidosis). e.g., COPD, Opioids.
      • Hyperventilation: PaCO2 < 35 mmHg (Alkalosis). e.g., Anxiety, PE.

    C. Clinical Utility

    • Diagnosing Respiratory Failure:
      • Type I (Hypoxemic): Oxygenation problem. PaO2: Low. PaCO2: Normal/Low. Example: Pneumonia, ARDS, Pulmonary Edema.
      • Type II (Hypercapnic): Ventilatory problem (CO2 retention). PaO2: Low. PaCO2: High. Example: COPD exacerbation, Opioid overdose.
    • Monitoring Critically Ill: Essential for sepsis, DKA, renal failure.
    • Guiding Therapy: Determines oxygen needs and helps adjust mechanical ventilator settings (rate/tidal volume) to normalize PaCO2.

    Objective 5: Briefly mention other specialized respiratory function tests.

    Beyond the foundational tests we've discussed, several other specialized pulmonary function tests exist. These tests often target specific clinical questions or provide more nuanced information about lung mechanics, control of breathing, or airway responsiveness.

    A. Airway Responsiveness Testing (Bronchial Challenge Tests)

    • Purpose: To identify or confirm airway hyperresponsiveness, a hallmark feature of asthma, even when baseline spirometry is normal.
    • Method: The patient inhales progressively increasing doses of a bronchoconstricting agent (most commonly methacholine, a cholinergic agonist) or undergoes physical challenges (e.g., exercise, hyperventilation of cold, dry air). Spirometry (FEV1) is measured after each dose.
    • Interpretation: A significant drop in FEV1 (typically ≥20%) at a low dose of the provocative agent indicates airway hyperresponsiveness. The dose that causes a 20% drop (PC20) is inversely related to the degree of hyperresponsiveness.

    Clinical Utility & Contraindications

    • Utility: Diagnosis of asthma when routine tests are inconclusive. Evaluating occupational asthma. Monitoring treatment effectiveness.
    • Contraindications: Severe airflow obstruction (FEV1 < 60-70% predicted). Recent myocardial infarction or stroke. Uncontrolled hypertension. Aortic aneurysm. Pregnancy.

    B & C. Exercise Testing

    Six-Minute Walk Test (6MWT)

    Functional Capacity

    • Purpose: Submaximal test measuring distance walked in 6 minutes on a flat surface. Assesses integrated cardiorespiratory/musculoskeletal function.
    • Method: Self-paced walking. SpO2 and heart rate monitored.
    • Interpretation: Distance (6MWD) compared to predicted. Desaturation is highly significant.
    • Utility: Prognosis in COPD/ILD/Heart Failure, monitoring rehab, assessing O2 needs.

    Cardiopulmonary Exercise Testing (CPET)

    Diagnostic / Maximal

    • Purpose: Comprehensive evaluation of responses to increasing physical demand. Differentiates cardiac vs. pulmonary causes.
    • Method: Treadmill/Cycle with continuous ECG, BP, SpO2, and exhaled gas analysis (VO2, VCO2).
    • Interpretation: Analyzes Peak VO2 (VO2max), anaerobic threshold, ventilatory efficiency.
    • Utility: Unexplained dyspnea, pre-op risk stratification, disability assessment.

    D. Inspiratory and Expiratory Muscle Strength (MIP/MEP)

    • Purpose: To assess the strength of the respiratory muscles.
    • Maximal Inspiratory Pressure (MIP or PImax): Measured at residual volume (RV) by having the patient generate a maximal inspiratory effort against an occluded airway.
    • Maximal Expiratory Pressure (MEP or PEmax): Measured at total lung capacity (TLC) by having the patient generate a maximal expiratory effort against an occluded airway.
    • Clinical Utility: Diagnosing neuromuscular diseases (ALS, Myasthenia Gravis). Assessing weaning from mechanical ventilation. Evaluating unexplained dyspnea/hypoventilation.

    E. Functional Imaging (HRCT & V/Q)

    While not "pulmonary function tests" in the classical sense, these provide critical functional information:

    • High-Resolution CT (HRCT): Provides detailed anatomical imaging. Used to visualize emphysema, fibrosis, bronchiectasis, and air trapping. Aids in correlating functional deficits (from PFTs) with structural changes.
    • V/Q Scan: Uses radioactive tracers to assess regional ventilation (air movement) and perfusion (blood flow). Primarily used for diagnosing Pulmonary Embolism (mismatch) and pre-op assessment for lung resections.

    These specialized tests complement the standard pulmonary function tests to provide a comprehensive evaluation of the respiratory system, leading to more accurate diagnoses and tailored management plans.

    Physiology: Respiratory Function Tests Exam
    Logo

    Respiratory Function Tests Exam

    Test your knowledge with these 32 questions.

    Control of Respiration (Neural and Chemical Regulation)

    Control of Respiration (Neural and Chemical Regulation)

    by with No Comment Physiology

    Control of Respiration: Neural and Chemical Regulation

    Control of Respiration (Neural and Chemical Regulation)

    Respiration is controlled by both the involuntary and voluntary nervous systems. Involuntary control, which governs automatic breathing, is managed by the respiratory centers in the brainstem (medulla oblongata and pons), which respond to blood levels of oxygen, carbon dioxide, and pH. Voluntary control comes from the cerebral cortex and allows you to control your breathing for activities like speaking or holding your breath.

    Overall Objective: To understand the neural pathways and chemical factors that regulate the rate and depth of breathing, ensuring appropriate gas exchange to meet metabolic demands and maintain blood gas homeostasis.

    Objective 1: Identify and describe the key neural control centers for respiration in the brainstem.

    The control of breathing is a complex process involving both voluntary and involuntary mechanisms. The involuntary, rhythmic control of breathing primarily originates in the brainstem, specifically in the medulla oblongata and the pons. These areas contain specialized groups of neurons that generate and modulate the respiratory rhythm.

    I. Medullary Respiratory Centers

    The medulla oblongata houses the most crucial respiratory control centers, responsible for setting the basic rhythm of breathing. These are broadly divided into two main groups: the Dorsal Respiratory Group (DRG) and the Ventral Respiratory Group (VRG).

    A. Dorsal Respiratory Group (DRG)

    Location:

    Located in the posterior portion of the medulla, near the nucleus of the tractus solitarius.

    Primary Function:

    The DRG is the most fundamental and active group involved in controlling the basic rhythm of breathing, especially during quiet (eupneic) respiration. It primarily controls inspiration.

    Neuronal Activity:
    • Contains inspiratory neurons that fire rhythmically.
    • These neurons generate a ramp-like signal: they start weakly and increase in intensity over approximately 2 seconds, then abruptly cease for about 3 seconds, allowing for elastic recoil and exhalation. This gradual increase helps to ensure a smooth, progressive filling of the lungs.
    Innervation:
    • Sends efferent (motor) signals via the phrenic nerves to the diaphragm.
    • Sends signals via the intercostal nerves to the external intercostal muscles.
    • Activation of these muscles causes the diaphragm to contract and flatten, and the rib cage to expand, leading to inspiration.
    Afferent Input:

    Receives sensory input (afferent signals) from:

    • Peripheral chemoreceptors: via glossopharyngeal (CN IX) and vagus (CN X) nerves, detecting changes in PO2, PCO2, and pH.
    • Lung receptors: via vagus (CN X) nerve, detecting stretch and irritation in the lungs and airways.

    This sensory input allows the DRG to modify the basic respiratory rhythm in response to physiological demands.

    B. Ventral Respiratory Group (VRG)

    Location:

    Located in the anterior portion of the medulla, extending from the brainstem to the upper spinal cord, including the pre-Bötzinger complex.

    Primary Function:

    The VRG is largely inactive during quiet breathing. It becomes active and crucial for generating the respiratory rhythm only when there is an increased ventilatory demand, such as during forceful (active) inspiration and expiration.

    Neuronal Activity:

    Contains both inspiratory and expiratory neurons.

    • Inspiratory neurons: When stimulated (e.g., by intense DRG signals or strong chemoreceptor input), they send signals to accessory muscles of inspiration (e.g., sternocleidomastoid, scalenes).
    • Expiratory neurons: When stimulated, they send signals to the internal intercostals and abdominal muscles, which are primarily active during forceful exhalation.
    Rhythm Generation (Pre-Bötzinger Complex):

    Current research suggests that a small area within the VRG, known as the pre-Bötzinger complex, is the primary site responsible for generating the basic respiratory rhythm. It acts as the pacemaker for breathing, relaying signals to the DRG.

    Innervation:
    • Inspiratory neurons: Innervate accessory muscles of inspiration.
    • Expiratory neurons: Innervate internal intercostal and abdominal muscles (for active expiration).
    Role in Forced Breathing:

    During exercise or respiratory distress, the DRG activates the VRG. The VRG then significantly increases the strength of both inspiratory and expiratory signals, leading to a deeper and more rapid breathing pattern.

    II. Pontine Respiratory Centers (Pontine Respiratory Group - PRG)

    The pons contains centers that modify and fine-tune the activity of the medullary respiratory centers, ensuring smooth transitions between inspiration and expiration. These are often collectively referred to as the Pontine Respiratory Group (PRG) and include the Pneumotaxic and Apneustic centers.

    A. Pneumotaxic Center

    Upper Pons (Nucleus Parabrachialis)

    Primary Function: Primarily acts to limit inspiration and fine-tune the respiratory rate. It essentially "switches off" the inspiratory ramp signal from the DRG.

    Effect: By shortening the inspiratory phase, it leads to:
    • Decreased tidal volume (shallower breaths).
    • Increased respiratory rate.
    Analogy: Think of it as an "off switch" or a "brake" for inspiration. A strong pneumotaxic signal reduces the duration of inspiration.

    Clinical Significance: Damage to this center can lead to prolonged inspiration and decreased respiratory rate.

    B. Apneustic Center

    Lower Pons

    Primary Function: Has an excitatory effect on the medullary inspiratory neurons, particularly the DRG. It essentially prolongs inspiration.

    Effect: If unopposed by the pneumotaxic center, it would lead to:
    • Prolonged, gasping inspirations followed by brief, insufficient expirations (a breathing pattern called apneusis).

    Interaction with Pneumotaxic Center: Normally, the pneumotaxic center overrides the apneustic center, preventing prolonged inspiration and ensuring rhythmic breathing.

    Clinical Significance: Damage to the pneumotaxic center or vagal nerves (which also inhibit inspiration) can allow the apneustic center to dominate, leading to apneustic breathing.

    Summary of Brainstem Control

    • Medulla (DRG & VRG): Generates the basic rhythm of breathing. DRG for quiet inspiration; VRG for forceful inspiration/expiration and contains the pacemaker (pre-Bötzinger complex).
    • Pons (Pneumotaxic & Apneustic): Modulates the medullary centers. Pneumotaxic center limits inspiration and increases rate; Apneustic center prolongs inspiration.

    This intricate interplay of neural centers ensures that breathing is a continuous, rhythmic process that can be finely adjusted to meet the body's changing metabolic demands.

    Objective 2: Explain the roles of central chemoreceptors in regulating breathing.

    The chemical control of respiration is paramount for maintaining arterial blood gas homeostasis (PCO2, PO2, and pH). Chemoreceptors are specialized sensory receptors that detect changes in the chemical composition of the blood and cerebrospinal fluid (CSF) and send signals to the respiratory centers in the brainstem to adjust ventilation accordingly.

    Central chemoreceptors are the most potent and important regulators of ventilation under normal physiological conditions.

    I. Location of Central Chemoreceptors

    Primary Location: Strategically located in the ventrolateral surface of the medulla oblongata, very close to the DRG and VRG respiratory centers. This proximity allows for a rapid and direct influence on breathing patterns.

    II. Primary Stimulus: Changes in Cerebrospinal Fluid (CSF) pH

    (Largely driven by arterial PCO2)

    Not directly sensitive to blood CO2: Central chemoreceptors are not directly sensitive to changes in arterial PCO2, but rather to the pH of the cerebrospinal fluid (CSF).

    The Crucial Link: Arterial PCO2 and CSF pH

    1. CO2 freely crosses the Blood-Brain Barrier (BBB):

    Unlike H+ and HCO3- ions, CO2 is lipid-soluble and readily diffuses across the blood-brain barrier from the systemic circulation into the CSF.

    2. Conversion to Carbonic Acid in CSF:

    Once in the CSF, CO2 reacts with water to form carbonic acid (H2CO3), a reaction facilitated by carbonic anhydrase (though less prevalent than in RBCs, it still occurs spontaneously).

    CO2 + H2O ↔ H2CO3 ↔ H+ + HCO3-
    3. CSF Lacks Significant Buffering Capacity:

    The CSF has a very low protein concentration, meaning it has a much weaker buffering capacity compared to blood plasma. Therefore, even small changes in CO2 entering the CSF can cause a significant change in CSF H+ concentration, and thus, a notable change in CSF pH.

    4. H+ Stimulates Chemoreceptors:

    It is these increased H+ ions (decreased pH) in the CSF that directly stimulate the central chemoreceptors.

    Relationship Summary:

    Increased arterial PCO2 → Increased CO2 in CSF → Increased H+ in CSF → Decreased CSF pH → Stimulation of central chemoreceptors → Increased ventilation.

    Decreased arterial PCO2 → Decreased CO2 in CSF → Decreased H+ in CSF → Increased CSF pH → Inhibition of central chemoreceptors → Decreased ventilation.

    III. Mechanism of Action

    • Detection: Central chemoreceptors detect changes in CSF H+ concentration (pH).
    • Signal Transmission: When stimulated, these receptors send excitatory signals directly to the medullary respiratory centers (DRG and VRG).
    • Ventilatory Response: The respiratory centers respond by increasing the rate and depth of breathing (hyperventilation).
    • Restoration of Homeostasis: This increased ventilation leads to a more rapid "blowing off" of CO2 from the blood. As arterial PCO2 decreases, less CO2 diffuses into the CSF, allowing CSF H+ concentration to fall and CSF pH to normalize. This, in turn, reduces the stimulation of the central chemoreceptors, completing the negative feedback loop.

    IV. Significance in Long-Term Control of Breathing

    Dominant Regulator: Under normal physiological conditions, arterial PCO2 (and thus CSF pH) is the most powerful and closely regulated chemical stimulus for breathing. Even small changes in PCO2 (e.g., a 1-2 mmHg increase) can significantly alter ventilation.

    Acute vs. Chronic Changes

    Acute Hypercapnia

    Central chemoreceptors respond quickly (within seconds to minutes) to acute changes in PCO2, causing a robust increase in ventilation.

    Chronic Hypercapnia (e.g., COPD)

    If high PCO2 levels persist for several days, the kidneys compensate by retaining bicarbonate ions (HCO3-) in the blood. These HCO3- ions eventually diffuse into the CSF, buffering the excess H+ ions. This "normalizes" the CSF pH, even though arterial PCO2 remains high.

    Clinical Relevance: COPD & Oxygen Administration

    In such patients, the central chemoreceptors become desensitized or "reset" to the chronically high PCO2. Their primary respiratory drive then shifts from PCO2 to the hypoxic drive (detected by peripheral chemoreceptors).

    The Danger: If supplemental oxygen is administered at high concentrations to these patients, their arterial PO2 may increase significantly, which can then depress the hypoxic drive from the peripheral chemoreceptors. Without the strong PCO2 drive (due to desensitization) or the hypoxic drive (due to O2 administration), the patient's respiratory drive can diminish, leading to hypoventilation, further CO2 retention, and potentially respiratory acidosis and coma.

    This is why oxygen administration in COPD patients needs to be carefully monitored and typically delivered at lower flow rates.

    Insensitivity to Hypoxia: Central chemoreceptors are essentially insensitive to changes in arterial PO2. This role is primarily handled by the peripheral chemoreceptors.

    In essence, central chemoreceptors are the body's primary "CO2 sensors," indirectly monitoring arterial CO2 levels by sensing CSF pH, and they are crucial for maintaining CO2 homeostasis.

    Objective 3: Explain the roles of peripheral chemoreceptors in regulating breathing.

    Peripheral chemoreceptors provide an additional layer of chemical control, primarily acting as the body's emergency sensors for oxygen levels and as a secondary sensor for CO2 and pH.

    I. Location of Peripheral Chemoreceptors

    These are specialized sensory organs located in specific arteries outside the brain.

    Carotid Bodies

    Location: Small, highly vascularized structures located bilaterally at the bifurcation of the common carotid arteries (where they split into internal and external carotid arteries).

    Innervation: Send afferent (sensory) signals to the medulla oblongata via the glossopharyngeal nerve (CN IX).

    Significance: Because they sample blood going to the brain, they are particularly important for ensuring adequate oxygen supply to the brain.

    Aortic Bodies

    Location: Scattered along the aortic arch.

    Innervation: Send afferent signals to the medulla oblongata via the vagus nerve (CN X).

    Significance: Monitor the arterial blood that will be distributed to the rest of the body.

    II. Primary Stimuli: Severe Decreases in Arterial PO2 (Hypoxia)

    Oxygen Sensitivity: Peripheral chemoreceptors are the body's primary and most important sensors for detecting changes in arterial oxygen levels.

    The Critical Threshold

    They are relatively insensitive to changes in PO2 until arterial PO2 falls below a critical threshold, typically around 60-70 mmHg.

    Below this level, their firing rate increases sharply and exponentially. This means they act more as an "emergency" oxygen sensor rather than a fine-tuner of normal PO2.

    Why 60-70 mmHg?

    This corresponds to the steep part of the oxygen-hemoglobin dissociation curve. Below this point, a small drop in PO2 leads to a significant decrease in hemoglobin saturation and oxygen content, which could rapidly become life-threatening.

    Response to Hypoxia: When activated by low PO2, they send strong excitatory signals to the DRG, leading to a significant increase in ventilation (hyperventilation).

    III. Secondary Stimuli: Increases in Arterial PCO2 and H+ (Decreased pH)

    PCO2 Sensitivity

    While central chemoreceptors are the dominant sensors for PCO2, peripheral chemoreceptors also respond to increases in arterial PCO2.

    Their response to CO2 is faster but quantitatively less powerful (about 20-30%) than that of the central chemoreceptors. This means they contribute to the overall ventilatory response to hypercapnia, particularly in its initial, acute phase.

    pH Sensitivity

    Peripheral chemoreceptors are directly sensitive to changes in arterial H+ concentration (pH), independent of PCO2.

    This is especially important in metabolic acidosis (e.g., diabetic ketoacidosis), where H+ levels rise without a primary increase in PCO2. In such cases, the peripheral chemoreceptors are crucial for stimulating hyperventilation to "blow off" CO2, thereby attempting to raise blood pH.

    IV. Mechanism of Action

    • Detection: Peripheral chemoreceptors monitor the arterial blood for changes in PO2, PCO2, and pH.
    • Signal Transmission: Upon stimulation (e.g., significant drop in PO2, rise in PCO2 or H+), they generate action potentials that are transmitted via the glossopharyngeal (carotid bodies) and vagus (aortic bodies) nerves to the medullary respiratory centers (primarily the DRG).
    • Ventilatory Response: The medullary centers, receiving this input, increase the firing rate of inspiratory neurons, leading to an increased rate and depth of breathing (hyperventilation).
    • Integrated Response: The overall ventilatory response to hypercapnia and acidosis is a combined effect of both central and peripheral chemoreceptor activity.

    V. Significance in Immediate, Emergency Responses and Clinical Relevance

    Hypoxic Drive & COPD Oxygen Therapy

    Hypoxic Drive: As mentioned in our previous discussion on central chemoreceptors, in individuals with chronic hypercapnia (e.g., severe COPD), the central chemoreceptors become desensitized to high PCO2. In these patients, the hypoxic drive (stimulation of peripheral chemoreceptors by low PO2) becomes the primary stimulus for breathing.

    Clinical Point Revisited:

    If a COPD patient with chronic hypercapnia is given high concentrations of supplemental oxygen, their arterial PO2 rises significantly. This rise in PO2 removes the hypoxic stimulus from the peripheral chemoreceptors, thus diminishing their main remaining drive to breathe.

    This can lead to severe hypoventilation, worsening hypercapnia, respiratory acidosis, and potentially coma or death. Therefore, oxygen therapy in these patients must be carefully managed to avoid suppressing their crucial hypoxic drive.

    Acute Hypoxemia:

    The peripheral chemoreceptors are vital for triggering a rapid ventilatory response to acute hypoxemia (e.g., at high altitude, during suffocation).

    Metabolic Acidosis:

    They are the sole chemoreceptors to respond to changes in pH that are not caused by changes in PCO2 (i.e., metabolic acidosis), driving the compensatory hyperventilation (Kussmaul breathing) seen in conditions like diabetic ketoacidosis.

    In summary, while central chemoreceptors are the primary sensors for CO2 and pH via CSF, peripheral chemoreceptors are indispensable for detecting critically low oxygen levels and for responding to metabolic acid-base disturbances, making them vital for acute and emergency respiratory regulation.

    Objective 4: Describe the various lung and airway receptors that influence breathing.

    Beyond the central control in the brainstem and chemical feedback from chemoreceptors, a variety of mechanoreceptors and irritant receptors located within the lungs and airways provide sensory input that modifies the breathing pattern. These receptors relay information predominantly via the vagus nerves (CN X) to the medullary respiratory centers.

    I. Pulmonary Stretch Receptors (Slowly Adapting Receptors)

    • Location: Found in the smooth muscle of the airways (trachea, bronchi, and bronchioles).
    • Stimulus: Activated by distension or stretching of the lung tissue during inspiration. As the lungs inflate, these receptors fire with increasing frequency.
    Reflex: The Hering-Breuer Reflex

    Mechanism: When these receptors are significantly stimulated (i.e., during deep inspiration, or in infants even during normal inspiration), they send inhibitory signals to the inspiratory neurons of the DRG.

    Effect: This inhibition terminates inspiration and therefore prolongs the expiratory phase. It acts as a protective mechanism to prevent overinflation of the lungs, particularly important in newborns and during exercise in adults. In resting adults, it may not play a major role until tidal volume exceeds approximately 1.5 liters.

    Adaptation: They are "slowly adapting" because they continue to fire as long as the stretch is maintained.

    II. Irritant Receptors (Rapidly Adapting Receptors)

    • Location: Located in the epithelium of the entire airway, from the trachea to the terminal bronchioles.
    • Stimulus: Activated by a wide variety of noxious stimuli:
      • Mechanical irritants (e.g., dust, foreign particles)
      • Chemical irritants (e.g., smoke, fumes, sulfur dioxide, ammonia)
      • Cold air
      • Inflammatory mediators (e.g., histamine, prostaglandins)
    Protective Reflexes:
    • Bronchoconstriction: Narrows the airways, limiting further entry of irritants.
    • Coughing: A forceful expulsion of air to clear the airways.
    • Sneezing: Similar to coughing, but typically for irritants in the nasal passages.
    • Hyperpnea/Shallow Breathing: Increased rate or shallow pattern depending on the irritant.

    Adaptation: They are "rapidly adapting" because they respond vigorously to the onset of a stimulus but then quickly decrease their firing rate even if the stimulus persists.

    III. J-Receptors (Juxtacapillary Receptors)

    • Location: Located in the alveolar-capillary walls, in the interstitial space between the pulmonary capillaries and the alveoli.
    • Stimulus: Activated by an increase in interstitial fluid volume or pressure (e.g., pulmonary edema, pneumonia, left heart failure) and by chemical agents such as histamine.
    Reflexes & Response:
    • Rapid, Shallow Breathing (Tachypnea): Increases the respiratory rate but with reduced tidal volume.
    • Bronchoconstriction (sometimes).
    • Dyspnea: Sensation of shortness of breath. Thought to be a major contributor to the feeling of breathlessness in conditions like pulmonary edema.
    Physiological Role: Their precise physiological role is still debated, but they are thought to be important in sensing pathological changes in the lung interstitium.
    Receptor Type Function/Reflex
    Pulmonary Stretch Prevent overinflation, modulate inspiratory duration (Hering-Breuer).
    Irritant Protect airways from noxious stimuli, trigger cough/bronchoconstriction.
    J-Receptors Respond to interstitial fluid changes, contribute to dyspnea and rapid shallow breathing.

    These receptors act as sophisticated sensors within the respiratory system, providing essential feedback to the brain to adjust ventilation and activate protective reflexes, ensuring both efficient gas exchange and the integrity of the airways.

    Objective 5: Identify other factors that influence respiratory control.

    Beyond the primary medullary and pontine centers, chemoreceptors, and pulmonary reflexes, several other physiological and psychological factors can exert significant influence over the rate and depth of respiration. These often involve higher brain centers or specialized sensory receptors throughout the body.

    I. Voluntary Control (Cerebral Cortex)

    Mechanism: The cerebral cortex, particularly the motor cortex, can temporarily override the brainstem's automatic respiratory centers. This allows for conscious control over breathing.

    Examples:
    • Holding Breath (diving).
    • Talking, Singing, Playing Wind Instruments.
    • Breath-holding for medical procedures (X-ray).
    • Voluntary Hyperventilation/Hypoventilation.
    The "Breaking Point":

    This voluntary control is ultimately limited. If CO2 levels rise too high (or O2 levels fall too low) during breath-holding, the involuntary drive from the medullary centers (primarily via central chemoreceptors sensing CO2) will eventually become so strong that it overrides voluntary inhibition, forcing a breath.

    II. Hypothalamic Influence (Emotion, Pain, Temperature)

    Mechanism: The hypothalamus, a key brain region for regulating homeostatic functions and emotional responses, can influence the respiratory centers.

    Emotion:

    Strong emotions (e.g., fear, anxiety, anger, excitement) can cause changes in breathing patterns (e.g., gasping, hyperventilation, sighing). Mediated by pathways from the limbic system to the hypothalamus.

    Pain:

    Sudden severe pain often causes a brief period of apnea followed by rapid, shallow breathing. Prolonged pain typically leads to an increase in respiratory rate.

    Temperature:
    • Increased Body Temperature (Fever): Increases respiratory rate (hyperpnea). Mechanism to increase heat loss.
    • Decreased Body Temperature (Hypothermia): Generally decreases respiratory rate and depth.

    III. Proprioceptors & V. Muscle Stretch Receptors (Exercise)

    Location: Sensory receptors located in muscles, tendons, and joints throughout the body.

    Mechanism: The "Anticipatory Response"

    When movement begins (e.g., at the start of exercise), these proprioceptors send excitatory signals to the medullary respiratory centers, causing an immediate increase in ventilation. This anticipatory response ensures that ventilation increases before there are significant changes in blood gases or pH due to increased metabolic activity.

    Significance: This "neurogenic drive" is a significant contributor to the rapid increase in breathing observed at the onset of exercise.

    IV. Baroreceptors (Blood Pressure)

    Location: Carotid sinuses and aortic arch.

    • Increased BP: Stimulation inhibits respiratory centers → temporary decrease in rate/depth.
    • Decreased BP: Reduced stimulation excites respiratory centers → increase in rate/depth.

    Significance: Plays a role in integrated cardiovascular/respiratory homeostasis, though less powerful than chemoreceptors.

    VI. Irritation of Upper Airways

    Receptors: Free nerve endings in nose, pharynx, larynx, trachea.

    Reflexes: Sneezing, coughing, bronchoconstriction, temporary apnea. Similar to lung irritant receptors but specific to the upper tract.

    These diverse influences demonstrate that respiration is not merely an automatic process driven by basic chemical needs, but a highly adaptable system integrated with our emotional state, physical activity, and protective reflexes.

    Objective 6: Explain how the body responds to changes in PCO2, PO2, and pH to maintain respiratory homeostasis.

    The respiratory system works tirelessly to maintain arterial partial pressures of carbon dioxide (PCO2) and oxygen (PO2), and arterial pH within very narrow physiological limits. This is achieved through a sophisticated negative feedback system involving chemoreceptors and medullary respiratory centers.

    I. Response to Hypercapnia (Increased Arterial PCO2)

    Definition: Hypercapnia is an abnormally high level of CO2 in the arterial blood (PaCO2 > 45 mmHg). It typically occurs due to hypoventilation (inadequate removal of CO2).

    Consequences:
    • Respiratory Acidosis: As CO2 combines with water to form carbonic acid (H2CO3) which then dissociates into H+ and HCO3-, the H+ concentration in the blood increases, causing a drop in pH.
    • Direct effect on tissues: High CO2 can have narcotic effects on the brain at very high levels.

    Body's Response:

    1. Central Chemoreceptors (Dominant Role):

    Increased PaCO2 readily diffuses across the blood-brain barrier into the CSF. In the CSF, CO2 is converted to H+, leading to a decrease in CSF pH. This decreased CSF pH strongly stimulates the central chemoreceptors in the medulla.

    2. Peripheral Chemoreceptors (Secondary, Faster Role):

    Increased PaCO2 also directly stimulates the peripheral chemoreceptors (carotid and aortic bodies). This response is faster but less powerful than the central chemoreceptor response to CO2.

    Physiological Outcome:
    • Overall Effect: Both sets of chemoreceptors send strong excitatory signals to the medullary respiratory centers (DRG and VRG).
    • Ventilatory Outcome: The respiratory centers respond by dramatically increasing the rate and depth of breathing (hyperventilation).
    • Restoration of Homeostasis: This increased ventilation "blows off" excess CO2 from the lungs, reducing PaCO2 back towards normal. As PaCO2 falls, CSF pH rises, and the stimulation of chemoreceptors decreases, completing the negative feedback loop.

    Summary: Increased PaCO2 is the most powerful ventilatory stimulus. A rise of just 1-2 mmHg in PaCO2 can double ventilation.

    II. Response to Hypoxemia (Decreased Arterial PO2)

    Definition: Hypoxemia is an abnormally low level of O2 in the arterial blood (PaO2 < 80 mmHg).

    Body's Response:

    Peripheral Chemoreceptors (Exclusive Role):
    • Central chemoreceptors are insensitive to changes in PO2.
    • The peripheral chemoreceptors (carotid and aortic bodies) are the only chemoreceptors that directly sense arterial PO2.
    • They become significantly stimulated when PaO2 drops below approximately 60-70 mmHg. Their firing rate increases exponentially below this threshold.
    Physiological Outcome:
    • Overall Effect: Stimulated peripheral chemoreceptors send excitatory signals to the medullary respiratory centers.
    • Ventilatory Outcome: The respiratory centers respond by increasing the rate and depth of breathing (hyperventilation).
    • Restoration of Homeostasis: This increased ventilation brings more oxygen into the alveoli, raising PaO2 back towards normal.

    Summary: Decreased PaO2 is a potent ventilatory stimulus, but only when it falls significantly below normal levels. It acts primarily as an emergency mechanism.

    III. Response to Acidosis/Alkalosis (Changes in Arterial pH)

    Definition: Acidosis (pH < 7.35) or alkalosis (pH > 7.45) refers to an imbalance in arterial blood pH.

    Metabolic Acidosis

    Decreased pH, Normal/Decreased PaCO2

    Primary Role: Peripheral chemoreceptors are directly sensitive to increased H+.

    Secondary Role: Central chemoreceptors play a delayed, indirect role if acidosis is prolonged.

    Outcome: Marked increase in ventilation (hyperventilation), often characterized by deep, rapid breaths known as Kussmaul respiration.

    Restoration: "Blowing off" CO2 reduces H+ concentration, raising pH back toward normal.

    Metabolic Alkalosis

    Increased pH, Normal/Increased PaCO2

    Primary Role: Decreased H+ (increased pH) inhibits peripheral chemoreceptors.

    Outcome: Decreased ventilation (hypoventilation).

    Restoration: Hypoventilation leads to CO2 retention, increasing H+ concentration and lowering pH back toward normal.

    Objective 7: Identify and describe common abnormal breathing patterns and their physiological basis.

    Understanding normal quiet breathing (eupnea) is essential, but equally important is the ability to recognize and interpret deviations from this pattern.

    I. Eupnea (Normal Breathing)

    Quiet, effortless, rhythmic breathing (12-20 breaths/min). Generated by medullary centers maintaining homeostasis.

    II. Apnea

    Cessation of breathing.

    • Voluntary: Breath-holding.
    • Reflexive: Pain, cold shock.
    • Pathological: Sleep apnea, brainstem lesions, opioid overdose.
    III. Dyspnea

    Subjective sensation of "shortness of breath." Complex sensation involving increased effort, ventilatory demand mismatch, and chemoreceptor stimulation. Common in heart failure, COPD, anxiety.

    IV. Tachypnea

    Rapid breathing (>20/min). Caused by acidosis, hypoxemia, fever, anxiety, pain.

    V. Bradypnea

    Slow breathing (<12/min). Caused by CNS depression (opioids), hypothermia, metabolic alkalosis.

    VI. Hyperpnea & VII. Kussmaul Respiration

    Hyperpnea: Increased depth/rate to meet metabolic demand (exercise, altitude).

    Kussmaul: Deep, rapid, labored breathing. Specific compensatory mechanism for severe metabolic acidosis (DKA) to blow off CO2.

    VIII. Cheyne-Stokes Respiration

    Cyclical pattern: gradual increase in volume/rate, then decrease, then apnea. Repeats.

    Mechanism (Unstable Feedback Loop): Heart failure/brain injury → Slow blood flow → Delayed signal to brain → Overshoot (hyperventilation) → Undershoot (apnea) → Cycle repeats.
    IX. Biot's (Ataxic)

    Irregular shallow breaths followed by irregular apnea. Indicates severe medullary damage (stroke, trauma). Pre-terminal.

    X. Apneustic

    Prolonged inspiratory pauses, short expirations. Indicates pontine damage disrupting the pneumotaxic center.

    Physiology: Control of Respiration Exam
    Logo

    Control of Respiration Exam

    Test your knowledge with these 30 questions.

    Gas Exchange and Transport

    Gas Exchange and Transport

    by with No Comment Physiology

    Gas Exchange &: Transport

    Gas Exchange and Transport

    Gas exchange is the process by which oxygen and carbon dioxide move between the lungs and the bloodstream, driven by simple diffusion along partial pressure gradients. This is coupled with the transport of these gases throughout the body via the circulatory system, primarily using hemoglobin in red blood cells. The entire process involves two main stages:

    I. External Respiration (in the Lungs)

    This is the exchange of gases between the air in the alveoli and the blood in the pulmonary capillaries.

    • Oxygen uptake: Inhaled air has a high partial pressure of oxygen (PO2 ≈ 100 mmHg) in the alveoli, while the deoxygenated blood in the capillaries has a low PO2 ≈ 40 mmHg. This gradient causes oxygen to diffuse rapidly from the alveoli into the blood.
    • Carbon dioxide release: The deoxygenated blood in the capillaries has a higher partial pressure of carbon dioxide (PCO2 ≈ 45 mmHg) compared to the air in the alveoli (PCO2 ≈ 40 mmHg). This causes carbon dioxide to diffuse from the blood into the alveoli to be exhaled.

    II. Internal Respiration (in the Tissues)

    This is the exchange of gases between the blood in systemic capillaries and the body's tissue cells.

    • Oxygen release: Oxygenated blood arriving at the tissues has a high PO2 ≈ 100 mmHg, while the metabolizing tissue cells have a low PO2 < 40 mmHg due to continuous consumption for cellular respiration. This gradient causes oxygen to dissociate from hemoglobin and diffuse into the cells.
    • Carbon dioxide uptake: Tissue cells produce carbon dioxide as a waste product, resulting in a high PCO2 > 45 mmHg compared to the blood in the capillaries (PCO2 ≈ 40 mmHg). Carbon dioxide diffuses from the cells into the blood.

    Objective 1: Describe the partial pressures of oxygen and carbon dioxide in atmospheric air, alveoli, arterial blood, and venous blood.

    To understand gas exchange, we first need to grasp the concept of partial pressure.

    1. Dalton's Law of Partial Pressures

    Dalton's Law states that in a mixture of non-reacting gases, the total pressure exerted is equal to the sum of the partial pressures of the individual gases.

    Ptotal = P1 + P2 + P3 + ... Pn

    Where Ptotal is the total pressure of the gas mixture and P1, P2, etc. are the partial pressures of each individual gas.

    The partial pressure of an individual gas in a mixture is the pressure that gas would exert if it alone occupied the volume. It is directly proportional to its percentage concentration in the mixture.

    Partial Pressure of Gas (Px) = % Concentration of Gas x Total Pressure
    Example Calculation (Atmospheric Air at Sea Level):

    Total Pressure = 760 mmHg. Composition:

    • Nitrogen (N2): ~79%
    • Oxygen (O2): ~21%
    • Carbon Dioxide (CO2): ~0.04%

    PO2 = 0.21 x 760 mmHg = ~160 mmHg

    2. Partial Pressures in Different Locations

    Gases always diffuse down their partial pressure gradients from an area of higher partial pressure to an area of lower partial pressure. This is the driving force for gas exchange.

    Let's examine the typical partial pressures of Oxygen (O2) and Carbon Dioxide (CO2) in four key locations:

    A. Atmospheric (Inspired) Air (at sea level, dry)

    This is the air we breathe in.

    PO2 (Atmospheric):
    Percentage: ~21%
    0.21 x 760 = ~160 mmHg
    PCO2 (Atmospheric):
    Percentage: ~0.04%
    0.0004 x 760 = ~0.3 mmHg
    (often rounded to 0 mmHg)

    B. Alveolar Air

    As atmospheric air enters the lungs, it mixes with the air already present in the dead space and alveoli, and it becomes saturated with water vapor. This significantly alters the partial pressures.

    Influencing Factors:
    • Water Vapor: At 37°C, water vapor pressure is 47 mmHg. This dilutes other gases (Effective pressure: 760 - 47 = 713 mmHg).
    • Gas Diffusion: CO2 continuously enters from blood; O2 continuously leaves into blood.
    PO2 (Alveolar - PAO2):
    ~104 mmHg
    Lower than atmospheric due to water vapor dilution and O2 diffusion into blood.
    PCO2 (Alveolar - PACO2):
    ~40 mmHg
    Higher than atmospheric due to CO2 diffusion from blood.

    C. Arterial Blood

    This is the blood leaving the pulmonary capillaries (oxygenated blood) and traveling to the systemic tissues.

    PO2 (Arterial - PaO2):
    ~95-100 mmHg
    Slightly lower than alveolar PO2 due to physiological shunts (bronchial circulation).
    PCO2 (Arterial - PaCO2):
    ~40 mmHg
    Same as alveolar PCO2; high solubility allows rapid equilibration.

    D. Venous Blood (Mixed Venous Blood)

    This is the blood returning to the lungs from the systemic tissues, carrying metabolic waste products.

    PO2 (Mixed Venous - PvO2):
    ~40 mmHg
    Lower than arterial because O2 was delivered to tissues.
    PCO2 (Mixed Venous - PvCO2):
    ~45 mmHg
    Higher than arterial because CO2 was picked up from tissues.

    Summary of Partial Pressures (Approximate Values at Sea Level)

    Location PO2 (mmHg) PCO2 (mmHg)
    Atmospheric Air 160 0.3
    Alveolar Air 104 40
    Arterial Blood 95-100 40
    Mixed Venous Blood 40 45

    Key Gradients for Gas Exchange

    • O2 gradient for diffusion (Alveoli to Pulmonary Capillaries):
      104 mmHg (alveolar) - 40 mmHg (venous) = 64 mmHg
    • CO2 gradient for diffusion (Pulmonary Capillaries to Alveoli):
      45 mmHg (venous) - 40 mmHg (alveolar) = 5 mmHg

    Note: Notice the much larger gradient for O2 compared to CO2. This is important because CO2 is much more soluble than O2, allowing it to diffuse efficiently even with a smaller pressure gradient.

    Checkpoint Question:

    Why is the partial pressure of oxygen in the alveoli (PAO2) significantly lower than the partial pressure of oxygen in atmospheric air (PO2)?

    Objective 2: Explain the principles governing gas exchange across the alveolar-capillary membrane (e.g., Dalton's Law, Henry's Law, Fick's Law of Diffusion).

    Gas exchange, both between the alveoli and pulmonary capillaries, and between systemic capillaries and tissues, is driven by fundamental physical laws. We've already touched upon Dalton's Law of Partial Pressures, which establishes the pressure gradient for individual gases. Now let's integrate Henry's Law and Fick's Law of Diffusion to understand how these gases actually move and dissolve.

    1. Dalton's Law of Partial Pressures (Recap)

    • Principle: The total pressure exerted by a mixture of gases is the sum of the partial pressures of the individual gases. The partial pressure of a specific gas is proportional to its concentration in the mixture.
    • Relevance to Gas Exchange: This law explains why gases move. Gases diffuse from an area where their partial pressure is higher to an area where it is lower. This partial pressure gradient is the primary driving force for gas exchange.
      • O2: High PO2 in alveoli, low PO2 in venous blood → O2 moves into blood.
      • CO2: High PCO2 in venous blood, low PCO2 in alveoli → CO2 moves into alveoli.

    2. Henry's Law

    Principle:

    When a gas is in contact with a liquid, the amount of gas that dissolves in the liquid is directly proportional to its partial pressure above the liquid, and its solubility coefficient in that liquid, at a given temperature.

    • The higher the partial pressure of a gas above a liquid, the more of that gas will dissolve into the liquid.
    • The higher the solubility of a gas in a specific liquid, the more of that gas will dissolve at a given partial pressure.
    Amount of dissolved gas = Px * Solubility Coefficient

    Where Px is the partial pressure of the gas.

    Relevance to Gas Exchange:

    • Loading and Unloading: Henry's Law explains how O2 and CO2 move between the gaseous phase (alveoli) and the liquid phase (blood plasma) and vice versa.
    • Solubility Differences: It highlights a critical difference between O2 and CO2:

      CO2 is about 20-24 times more soluble in plasma than O2. This is extremely important because even though the partial pressure gradient for CO2 across the alveolar-capillary membrane (typically 5 mmHg) is much smaller than for O2 (typically 64 mmHg), CO2 can still diffuse across the membrane very rapidly and efficiently due to its high solubility. This ensures efficient CO2 elimination despite the small gradient.

    3. Fick's Law of Diffusion

    Fick's Law quantifies the rate at which a gas diffuses across a membrane.

    V gas = (A * D * ΔP) / T
    V gas: Rate of gas diffusion.
    A (Area): Surface area of the membrane. (Larger area = faster diffusion).
    D (Diffusion Coefficient): Depends on solubility/molecular weight. (D ∝ Solubility / √MW).
    ΔP (Pressure Gradient): Difference in partial pressure. (Larger gradient = faster diffusion).
    T (Thickness): Membrane thickness. (Thicker membrane = slower diffusion).

    Relevance to Gas Exchange:

    This law combines the key anatomical and physiological factors that determine how effectively gas moves between the alveoli and blood.

    • Surface Area (A): The human lungs have an enormous alveolar surface area (estimated 50-100 m², about the size of a tennis court). Diseases like emphysema reduce this area, impairing diffusion.
    • Diffusion Coefficient (D): As mentioned with Henry's Law, CO2 has a much higher diffusion coefficient than O2 due to its greater solubility, meaning it diffuses much faster than O2 for a given partial pressure gradient.
    • Partial Pressure Gradient (ΔP): This is the driving force from Dalton's Law. Maintaining appropriate partial pressure differences is crucial.
    • Thickness (T): The alveolar-capillary membrane is incredibly thin (0.2-0.6 µm). Diseases like pulmonary fibrosis or pulmonary edema increase this thickness, significantly impairing gas diffusion.

    In Summary:

    • Dalton's Law explains the direction and driving force (gradients).
    • Henry's Law explains solubility and dissolving into liquid.
    • Fick's Law describes the rate of diffusion integrating area, thickness, gradients, and solubility.
    Checkpoint Question:

    Given that the partial pressure gradient for O2 across the alveolar-capillary membrane is much larger (64 mmHg) than for CO2 (5 mmHg), why do O2 and CO2 still diffuse across the membrane at roughly equal rates under normal physiological conditions?

    Objective 3: Discuss the factors affecting the efficiency of gas exchange at the alveolar-capillary membrane.

    The efficiency of gas exchange across the delicate alveolar-capillary membrane is paramount for maintaining proper blood gas levels. Several interconnected factors, derived directly from the laws we just discussed (especially Fick's Law), determine this efficiency.

    1. Partial Pressure Gradients of O2 and CO2

    How it affects efficiency: This is the most fundamental driving force (Dalton's Law). The steeper the gradient for a gas, the faster it will diffuse.

    • For O2: PO2 alveoli (~104 mmHg) >> PO2 venous blood (~40 mmHg). Large gradient ensures rapid uptake.
    • For CO2: PCO2 venous blood (~45 mmHg) >> PCO2 alveoli (~40 mmHg). Smaller gradient sufficient due to high solubility.
    Factors influencing gradients:
    • Alveolar ventilation: Maintains PAO2 and PACO2. Hypoventilation reduces gradients.
    • Perfusion: Brings deoxygenated blood to maintain gradients.
    • Altitude: Low atmospheric PO2 reduces alveolar PO2 and the gradient.

    2. Thickness of the Respiratory Membrane

    How it affects efficiency: Per Fick's Law, diffusion is inversely proportional to thickness. A thicker membrane slows down diffusion.

    Normal state: Extremely thin (0.2-0.6 µm).

    Pathological conditions causing increased thickness:
    • Pulmonary Edema: Fluid accumulation in interstitial space.
    • Pulmonary Fibrosis: Scarring/thickening of tissue.
    • Pneumonia: Inflammatory exudates.

    These conditions primarily impair O2 diffusion (less soluble) more than CO2.

    3. Surface Area of the Respiratory Membrane

    How it affects efficiency: Rate of diffusion is directly proportional to surface area.

    Normal state: Immense surface area (50-100 m²).

    Pathological conditions causing decreased surface area:
    • Emphysema: Destruction of alveolar walls, merging alveoli.
    • Lung Resection: Surgical removal.
    • Tumors/Atelectasis: Reduced functional area.

    4. Ventilation-Perfusion (V/Q) Matching

    How it affects efficiency: Requires a close match between ventilation (V) and perfusion (Q).

    Ideal V/Q ratio: Around 0.8-1.0.

    High V/Q Ratio ("Dead Space")

    Ventilation exceeds perfusion (e.g., pulmonary embolism). Ventilated air doesn't exchange gas effectively.

    Low V/Q Ratio ("Shunt")

    Perfusion exceeds ventilation (e.g., pneumonia, atelectasis). Blood remains poorly oxygenated, reducing arterial PO2.

    5. Diffusion Coefficient of Gases

    How it affects efficiency: Depends on solubility and molecular weight.

    • CO2 vs. O2: CO2 is ~20-24 times more soluble. Its diffusion coefficient is ~20 times greater than O2.
    • Result: CO2 diffuses much more rapidly despite the smaller gradient.
    Clinical Relevance:

    When diffusion capacity is impaired (e.g., thick membrane), O2 diffusion is affected much more severely than CO2. A patient may present with hypoxemia (low O2) but a relatively normal PCO2.

    Checkpoint Question:

    A patient with severe pulmonary edema (fluid in the interstitial space) is likely to experience more significant problems with oxygenation (hypoxemia) than with carbon dioxide elimination (hypercapnia) in the initial stages. Explain why, using the factors discussed above.

    Objective 4: Explain the mechanisms of oxygen transport in the blood, including the role of hemoglobin and the oxyhemoglobin dissociation curve.

    Once oxygen diffuses from the alveoli into the blood, it needs to be transported efficiently to the metabolically active tissues. Oxygen is transported in two main forms:

    1. Oxygen Dissolved in Plasma (Small Amount)

    • Mechanism: A small percentage of oxygen (~1.5%) dissolves directly into the blood plasma.
    • Amount: For every mmHg of PO2, about 0.003 mL of O2 dissolves in 100 mL of blood.
    Significance:

    While small in quantity (at an arterial PO2 of 100 mmHg, only ~0.3 mL O2/100 mL blood), this fraction is critically important because:

    • It's the only form of oxygen that exerts a partial pressure.
    • It creates the partial pressure gradient for diffusion into the tissues.
    • It serves as the "gateway" for O2 to bind to hemoglobin.

    2. Oxygen Bound to Hemoglobin (Major Amount)

    Mechanism: The vast majority of oxygen (~98.5%) is transported bound reversibly to the iron atoms within the heme groups of hemoglobin (Hb) inside red blood cells.

    Hemoglobin Structure

    • Composed of four subunits (2 alpha, 2 beta).
    • Each subunit contains a heme group with an iron atom (Fe2+).
    • Each iron atom binds one O2 molecule (Max 4 O2 per Hb).

    Definitions & Capacity

    • Oxyhemoglobin (HbO2): Hb with bound oxygen.
    • Deoxyhemoglobin (HHb): Hb without bound oxygen.
    • Capacity: Each gram of Hb carries ~1.34 mL O2. (Normal 15 g/dL = ~20 mL O2/100 mL blood).

    3. The Oxyhemoglobin Dissociation Curve

    This S-shaped (sigmoidal) curve represents the relationship between partial pressure of oxygen (PO2) and hemoglobin saturation (%).

    Plateau (High PO2 - Lungs)

    At Lung PO2 (100 mmHg): Hb is ~97-98% saturated.

    Significance: The flat upper part provides a "safety margin." Large drops in PO2 (e.g., to 60 mmHg) result in only small decreases in saturation, ensuring loading.

    Steep Slope (Low PO2 - Tissues)

    At Tissue PO2 (40 mmHg): Saturation drops to ~75%.

    Significance: Small drops in tissue PO2 cause large unloading of O2. Crucial for active tissues (PO2 < 20 mmHg) to receive massive O2 release.

    4. Factors Shifting the Curve

    Releases O2

    Right Shift (Decreased Affinity)

    "Bohr Effect" - Favors unloading to tissues.

    • PCO2
    • Acidity (H+) / Low pH
    • Temperature
    • 2,3-BPG
    Holds O2

    Left Shift (Increased Affinity)

    Favors loading in lungs.

    • PCO2
    • Acidity / High pH
    • Temperature
    • 2,3-BPG
    • HbF (Fetal Hemoglobin)
    Checkpoint Question:

    During intense exercise, a person's muscle tissue produces more CO2 and generates more heat. How do these changes affect the oxyhemoglobin dissociation curve, and what is the physiological advantage of this shift?

    Objective 5: Explain the mechanisms of carbon dioxide transport in the blood.

    Carbon dioxide (CO2) is a metabolic waste product constantly produced by body cells. It is transported in the blood in three main forms:

    Form Percentage
    Dissolved in Plasma 7-10%
    Carbaminohemoglobin 20-23%
    Bicarbonate Ions (HCO3-) 70%

    1. Dissolved in Plasma

    Creates the PCO2 gradient for diffusion. It is the only form that can diffuse across membranes.

    2. Carbaminohemoglobin

    CO2 binds to protein (globin), not heme. Favored by deoxygenated Hb (Haldane Effect).

    3. As Bicarbonate Ions (HCO3-) (Major Amount)

    This is the most significant mechanism (70%) and is crucial for buffering blood pH.

    A. Process in Systemic Capillaries (Loading)

    1. CO2 Entry: Diffuses from tissues into RBCs.
    2. Conversion: CO2 + H2O ↔ H2CO3 (Catalyzed by Carbonic Anhydrase).
    3. Dissociation: H2CO3 ↔ H+ + HCO3-.
    4. Buffering: H+ is buffered by hemoglobin (H+ + Hb → HHb).
    5. Chloride Shift: HCO3- diffuses out to plasma; Cl- enters RBC to maintain electrical neutrality.

    B. Process in Pulmonary Capillaries (Unloading)

    1. Reversal of Chloride Shift: HCO3- re-enters RBC; Cl- moves out.
    2. Reformation: HCO3- + H+ (released from Hb as O2 binds) → H2CO3.
    3. Conversion: H2CO3 → CO2 + H2O (Catalyzed by CA).
    4. Diffusion: CO2 diffuses into plasma and then into alveoli for exhalation.
    The Haldane Effect

    Describes the relationship between O2 binding and CO2 transport.

    • Principle: Deoxygenated Hb (systemic) has greater affinity for CO2 and H+. Oxygenated Hb (pulmonary) has reduced affinity.
    • Significance: Enhances CO2 loading in tissues (where Hb is deoxygenated) and CO2 unloading in lungs (where Hb becomes oxygenated).
    Checkpoint Question:

    A person is experiencing severe metabolic acidosis (excess H+ in the blood). How might the body's mechanisms for CO2 transport respond to help compensate for this acidosis?

    Objective 6: Describe the concept of ventilation-perfusion (V/Q) matching and its importance for efficient gas exchange.

    For optimal gas exchange, it is not enough to simply ventilate the lungs and perfuse them with blood. The amount of air delivered to the alveoli (ventilation, V) must be appropriately matched with the amount of blood flowing through the pulmonary capillaries (perfusion, Q). This relationship is known as Ventilation-Perfusion (V/Q) Matching.

    1. Defining Ventilation (V) and Perfusion (Q)

    Ventilation (V)

    The volume of fresh air reaching the alveoli per minute.

    Normal ≈ 4-5 L/min
    Perfusion (Q)

    The volume of blood flowing through the pulmonary capillaries per minute (Cardiac Output).

    Normal ≈ 5 L/min

    2. The Ideal V/Q Ratio

    • Ideal: In a perfectly ideal lung, every alveolus would be perfectly ventilated and perfectly perfused, resulting in a V/Q ratio of 1.0.
    • Healthy/Actual: However, in a healthy lung, the overall V/Q ratio is approximately 0.8 (e.g., 4 L/min ventilation / 5 L/min perfusion). This slight mismatch is normal and due to physiological differences in ventilation and perfusion throughout the lung.

    3. Physiological Variations in V/Q Ratio

    Due to gravity, both ventilation and perfusion are not uniform throughout the lung, especially in an upright person.

    Apex (Top) of Lung

    • Ventilation: Lower than at the base (alveoli are stretched/less compliant).
    • Perfusion: Significantly lower than at the base (harder to flow against gravity).
    • V/Q Ratio: High (> 1.0)
    • Note: Ventilation is relatively better than perfusion. Referred to as having "physiological dead space".

    Base (Bottom) of Lung

    • Ventilation: Higher than at the apex (alveoli less stretched/more compliant).
    • Perfusion: Significantly higher than at the apex (gravity assists flow).
    • V/Q Ratio: Low (< 1.0, approx 0.6)
    • Note: Perfusion is relatively better than ventilation. Referred to as having "physiological shunt".

    Despite these regional differences, the overall V/Q matching is remarkably efficient in a healthy lung.

    4. Consequences of V/Q Mismatch

    V/Q mismatch is the most common cause of hypoxemia (low arterial PO2) in many lung diseases.

    Low V/Q Ratio (Perfusion > Ventilation)

    "Shunt-like" effect

    • Definition: Alveoli are well-perfused but poorly ventilated (e.g., airway obstruction, fluid).
    • Result: Blood passes without picking up O2. "Venous admixture" lowers arterial PO2.
    • Examples: Pneumonia, atelectasis, pulmonary edema, asthma.
    • Effect on Blood Gases: Low PO2, normal/elevated PCO2.

    High V/Q Ratio (Ventilation > Perfusion)

    "Dead Space-like" effect

    • Definition: Alveoli are well-ventilated but poorly perfused (e.g., reduced blood flow).
    • Result: Ventilated air does not contact enough blood. Increases "physiological dead space".
    • Examples: Pulmonary embolism, emphysema (capillary destruction), low cardiac output.
    • Effect on Blood Gases: Increased PCO2 (if severe), normal PO2 or mild hypoxemia.

    5. Body's Compensatory Mechanisms

    The body has local regulatory mechanisms to optimize V/Q matching:

    Hypoxic Pulmonary Vasoconstriction
    • Mechanism: If an alveolus is poorly ventilated (low PAO2), the pulmonary arterioles supplying it constrict.
    • Purpose: Diverts blood flow away from poorly ventilated areas to better-ventilated areas.
    • Unique to pulmonary circulation; systemic hypoxia causes vasodilation.
    Bronchoconstriction (Low PCO2)
    • Mechanism: If an area is poorly perfused (high V/Q), leading to low local PCO2, bronchioles constrict.
    • Purpose: Reduces ventilation to poorly perfused areas, redirecting air to better-perfused areas.

    6. Importance of V/Q Matching

    • Efficient Gas Exchange: Ensures O2 is loaded and CO2 is removed effectively.
    • Homeostasis: Critical for maintaining arterial PO2 and PCO2 within limits.
    • Clinical Relevance: Hallmark of many respiratory diseases.

    Conclusion of Module 7, Section III

    We have now covered the complete journey of oxygen from the atmosphere to the blood, and carbon dioxide from the blood to the atmosphere, detailing the physical laws, anatomical features, and physiological mechanisms that govern this vital process.

    Final Review Question:

    Consider a patient who has experienced a severe acute asthma attack, leading to widespread bronchoconstriction. How would this primarily affect their V/Q ratio, and what would be the immediate impact on their blood gas levels (PO2 and PCO2)? How would the body attempt to compensate?

    How V/Q Ratios are Determined and Why They Vary

    The V/Q ratio represents the ratio of alveolar ventilation (V̇A) to pulmonary blood flow (Q̇c).

    V/Q =
    Alveolar Ventilation (L/min)
    Pulmonary Blood Flow (L/min)
    Formula used to calculate the efficiency of matching air to blood.

    1. Overall V/Q Ratio (Typically ~0.8)

    Measured Values at Rest:
    • Total Alveolar Ventilation (V̇A): Approximately 4-5 L/min.
      Calculated from minute ventilation (tidal volume x respiratory rate) minus anatomical dead space ventilation.
    • Total Pulmonary Blood Flow (Q̇c): Approximately 5 L/min.
      Equal to the cardiac output of the right ventricle.
    Calculation:
    V/Q = 4 L/min / 5 L/min = 0.8
    V/Q = 5 L/min / 5 L/min = 1.0

    So, the overall V/Q ratio of 0.8-1.0 is simply a division of the average measured total alveolar ventilation by the average measured total pulmonary blood flow.

    2. Regional V/Q Variations (Apex vs. Base)

    This is where it gets more complex and is based on experimental observations, primarily due to the effects of gravity in an upright lung.

    Perfusion (Q) Gradient

    • Gravity: Significantly affects blood flow. In an upright person, blood tends to pool at the bottom (base).
    • Hydrostatic Pressure: The pressure of the blood column is highest at the base and lowest at the apex. This means pulmonary arterial pressure is highest at the base, leading to greater distension of capillaries and more blood flow.
    • Result: Blood flow (Q) is much higher at the base than at the apex.
      • Apex: Perfusion can be almost zero (Zone 1 of West's Lung Zones).
      • Base: Perfusion is highest (Zone 3).
    • Quantification: Perfusion at the base might be 5-10 times higher than at the apex.

    Ventilation (V) Gradient

    • Pleural Pressure: Gravity makes pleural pressure more negative at the apex and less negative (or more positive) at the base.
    • Alveolar Size & Compliance:
      • At Apex: The more negative pressure stretches alveoli more at rest. They are larger but less compliant (stiffer). They are "full" at the start, so they expand less with each breath.
      • At Base: The less negative pressure means alveoli are smaller and less stretched at rest. They are more compliant. They expand more with each breath.
    • Result: Ventilation (V) is higher at the base than at the apex, though the gradient is less steep than for perfusion.
    • Quantification: Ventilation at the base might be 2-3 times higher than at the apex.

    3. Calculating Regional V/Q (Conceptual)

    The Apex

    High Ratio

    Since V is relatively low and Q is very low (even lower than V):

    Low V
    Very Low Q
    = High V/Q (> 1.0)
    Hypothetical Example:

    V_apex = 0.2 L/min
    Q_apex = 0.05 L/min
    Ratio = 4.0

    The Base

    Low Ratio

    Since V is relatively high and Q is very high (even higher than V):

    High V
    Very High Q
    = Low V/Q (< 1.0)
    Hypothetical Example:

    V_base = 0.8 L/min
    Q_base = 1.2 L/min
    Ratio = 0.67

    Physiology: Gas Exchange and Transport Quiz
    Logo

    Gas Exchange and Transport

    Test your knowledge with these 30 questions.